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Shigella flexneri causes bacterial dysentery in humans by invading colonic 
epithelial cells, and then replicating and moving within the host cell cytoplasm to spread 
intercellularly to neighboring epithelial cells. Analysis of S. flexneri phospholipids 
revealed that cardiolipin, a large anionic phospholipid that localizes to the inner leaflet at 
the poles of Gram-negative bacterial membrane, makes up approximately 7% of S. 
flexneri’s total phospholipids and is found in equal proportions between the inner and 
outer membrane. To characterize the mechanisms S. flexneri uses to synthesize and 
transport cardiolipin, a series of mutants were construed that disrupted one of the three 
putative cardiolipin synthases, clsA, clsB, and clsC, or transporter, pbgA. It was 
determined that ClsA is the major cardiolipin synthase of S. flexneri and the level of 
phosphatidylglycerol increases in both the inner and outer membrane in the absence of 
cardiolipin. In addition, PbgA transports cardiolipin and phosphatidylglycerol to the S. 
flexneri outer membrane, but has no effect on the inner membrane phospholipid 
composition. Both the clsA and pbgA mutants were unable to form wild type plaques in 
cultured epithelial cells, and time-lapse microscopy revealed that the clsA mutant was 
less motile intracellularly and unable to divide during intracellular growth, while the 
 
 viii 
pbgA mutant grew normally but was non-motile. This suggests inner membrane 
cardiolipin is required for cell division and outer membrane anionic phospholipids are 
required for motility. Unipolar localization of S. flexneri virulence protein IcsA, a 
member of the auto-transporter protein family, provides the mechanism for intracellular 
mobility through the polymerization of host actin. Analysis of IcsA localization on the 
surface of the clsA and pbgA mutants revealed reduced and pinpoint (respectively) levels 
of polar localized IcsA; however, both mutants displayed wild type levels of outer 
membrane IcsA, and surface exposed IcsA passenger domain. Protein-lipid co-
sedimentation assays revealed a direct interaction of the polar targeting region in the 
passenger domain of IcsA with cardiolipin, and to a lesser extent with 
phosphatidylglycerol. We propose a novel model for IcsA polar localization directed by 
outer membrane anionic phospholipids, where outer membrane cardiolipin directs IcsA 
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1. Global burden of Shigella species 
Shigella species are the causative agent for shigellosis, a form of bacterial 
dysentery, in humans (Musher & Musher, 2004). Shigellosis is highly contagious, and it 
is estimated that as few as 10 bacterial cells are required to initiate infection, which 
typically results from the consumption of fecal contaminated food or water sources 
(DuPont et al., 1989). The disease symptoms, include painful abdominal craping, fever, 
bloody diarrhea, and in some more serious cases arthritis, blood stream infections, 
seizures, and hemolytic-uremic syndrome, are the results of damage to the colonic 
epithelial layer by Shigella and subsequent inflammatory immune response of the host. 
People who are immune compromised, children under the age of 5, and the elderly are at 
risk for a more severe illness and death (Kotloff et al., 2013). 
Each year, there are hundreds of millions of cases of shigellosis, with death rates 
as high as 15% in some countries (Bardhan et al., 2010). Most deaths resulting from 
shigellosis are among children under the age of five (Ashkenazi et al., 2003). Shigellosis 
rates are highest in developing countries with poor sanitation, affecting mostly children 
and the urban poor (Thapar & Sanderson, 2004). In developed countries, shigellosis 
incidence rates are lower; however, where there is overcrowding or close contact, such as 
day-care centers, prisons, and military barracks, shigellosis spreads rapidly. Programs 
aimed at improving water and sanitation systems have been successful at reducing 





Shigellosis symptoms begin 24-48 hours after infection, and usually last about 5-7 
days (Schroeder & Hilbi, 2008). In most cases, symptoms resolve on their own; however, 
in more severe cases, antibiotics are necessary to reduce the duration of the disease and to 
clear the disease symptoms. The increased frequency of antimicrobial resistance among 
many Shigella species complicates shigellosis treatment. In 2013, the CDC declared 
antibiotic-resistant Shigella as an urgent threat to the United States and invoked the 
World Health Organization to launch global vaccine development programs to prevent 
Shigella outbreaks (Vohra & Blakely, 2013). Most recently, in 2017, the World Health 
Organization classified fluoroquinolone-resistant Shigella species a global priority 
pathogen for research and development of new antibiotics. The identification of a novel 
target to treat and to prevent shigellosis would alleviate the global burden of Shigella 
species. 
Shigella species are members of the Enterobacteriacae family and classified into 
four species based on serological differences; Shigella dysenteriae (Group A), Shigella 
flexneri (Group B), Shigella boydii (Group C), and Shigella sonnei (Group D) (Lan & 
Reeves, 2002). S. dysenteriae type 1 encodes an exotoxin, shiga toxin, causing the most 
severe form of shigellosis, and it is responsible for most Shigella-related epidemics in 
Africa and Asia (Bhattacharya et al., 2003). S. sonnei is responsible for most shigellosis 
cases in developed countries. This is thought to be a result of improved drinking water 
conditions, where cross-reactive Plesiomonas shigelloides have been eliminated, causing 
a reduction in passive immunity against S. sonnei (Thapar & Sanderson, 2004). S. 
flexneri is responsible for most shigellosis in developing countries, is the most frequently 
isolated Shigella spp. and is the most frequent cause of shigellosis-related morbidity and 




dysenteriae and S. flexneri are labeled as the biggest public health threat of all Shigella 
species (Kotloff et al., 1999). S. flexneri is most commonly used to study the mechanism 




2. Shigella flexneri pathogenesis 
Upon host ingestion of fecal contaminated food or water, S. flexneri travels 
through the digestive tract to the large intestine, where infection starts and the damage 
associated with shigellosis occurs (Schroeder & Hilbi, 2008). Once in the colon, S. 
flexneri is transcytosed through epithelial M-cells to the basolateral side of the epithelium 
where invasion begins (Sansonetti et al., 1996) (Figure 1). The bacteria can be 
endocytosed by macrophages; however, the bacteria induce rapid pyroptosis of the 
macrophages, allowing the bacteria access to the basolateral face of the colonic 
epithelium (Zychlinsky et al., 1992). 
Shigella spp. are closely related to Escherichia coli, but encode a number of 
accessory virulence determinants, many of which are encoded on a large plasmid 
(Sansonetti et al., 1982), that give them the ability to have an intracellular life. The 
process by which S. flexneri infects human epithelial cells is highly controlled and 
complex. Regulation of infection is governed by a multi-step gene cascade containing 
three plasmid encoded virulence master regulators virF, virB, and mxiE (Makino et al., 
1986; Sansonetti et al., 1982). virF is activated by increased temperature (37°C), low pH, 
and changes in osmolality; repression of virF by the nucleoid factors H-NS is alleviated 
upon intestinal tract entry (Schroeder & Hilbi, 2008; Tobe et al., 1991), resulting in 
expression of the major virulence master regulator VirF. 
VirF induces expression of the actin polymerization gene icsA and of a second 
virulence master regulator, virB. VirB activates expression of genes that are required for 
host cell entry, including the Type Three Secretion System (T3SS) machinery and the 
primary effector proteins (Adler et al., 1989). Invasion of host epithelial cells begins 




effector proteins into host cell cytoplasm through the T3SS (High et al., 1992). Primary 
effector proteins induce host cytoskeletal rearrangement and bacteria are phagocytosed 
into a host vacuole. The vacuole is lysed, releasing the bacteria into the host cell 
cytoplasm. Dumping of effector proteins relieves repression of the third master virulence 
regulator mxiE (Sansonetti, 2001). MxiE activates the expression of secondary effector 
proteins encoded in the mxiE regulon, and upon translation, these proteins are 
immediately released through the T3SS (Mavris et al., 2002). 
Once in the host cytoplasm, S. flexneri rapidly replicates, and moves via IcsA-
mediated host actin polymerization (Bernardini et al., 1989; Goldberg & Theriot, 1995; 
Sansonetti, 2001). Re-activation of the T3SS is required to initiate infection of adjacent 
cells (Dragoi & Agaisse, 2015; Kuehl et al., 2014; Page et al., 1999) (Figure 1). The 
process of cell-to-cell spread repeats, and epithelial cells infected with S. flexneri 
eventually undergo necrosis. This results in a painful inflammatory immune response, 






 Schematic of S. flexneri pathogenesis. Figure 1.
Shigella is acquired through the ingestion of fecal contaminated substances. Once 
Shigella reaches the large intestine, it is transcytosed to the basolateral face of the 
intestinal epithelium, and invades using a specialized T3SS. Shigella spreads 






2.1 MECHANISMS USED TO STUDY S. FLEXNERI PATHOGENESIS. 
In vitro cell culture models have been used extensively to study the stages of S. 
flexneri infection. Human epithelial cells lines, such as Henle-407, are infected with S. 
flexneri and stained with Giemsa to visualize cell invasion (Figure 2A) (Hale & Formal, 
1981). Alternatively, spread can be measured using plaque assays where Henle-407 
monolayers are infected and stained with Giemsa after an extended period of time (Figure 
2B) (Oaks et al., 1985). 
Genes encoded on the S. flexneri virulence plasmid have been extensively studied 
and are well characterized for their role in pathogenesis. The mechanism by which S. 
flexneri uses its T3SS to invade host tissue has been characterized, and, more recently, 
the dynamic process of intercellular spread is becoming better understood. Studies have 
shown that intercellular spread by S. flexneri is T3SS dependent (Allaoui et al., 1992; 
1993; 1995; Andrews et al., 1991; Venkatesan et al., 1992), and mutants that are 
defective in actin polymerization are also unable to spread to adjacent host cells 
(Bernardini et al., 1989; Hong & Payne, 1997; Makino et al., 1986; Sandlin et al., 1995). 
However, many questions remain regarding the role of non-essential, chromosomal 
encoded genes in S. flexneri pathogenesis. Here, we take a closer look at these 






 Cultured epithelial cells are used to study S. flexneri infection. Figure 2.
(A) S. flexneri T3SS is required for epithelial cell invasion. Semi-confluent 
monolayers of Henle-407 cells are infected with S. flexneri for 90 min and Giemsa 
stained to visualize bacteria within the cytoplasm. (B) S. flexneri IcsA is required for cell-
to-cell spread. Confluent monolayers of Henle-407 cells are infected with S. flexneri for 
72 hr, and Giemsa stained to visualize bacterial plaque formation indicating cell-to-cell 





3. The Gram-negative bacterial membrane 
In order for S. flexneri to successfully cause disease it must be able to quickly 
adapt to survive a wide variety of environments, such as the acidic environment of the 
stomach and intracellular environment of epithelial cells. Because S. flexneri is a Gram-
negative bacteria (Schroeder & Hilbi, 2008), the outer membrane serves as the first line 
of defense against environmental stress (Needham & Trent, 2013). The Gram-negative 
bacterial cell envelope consists of a double membrane separated by a periplasmic space 
containing a thin peptidoglycan cell wall (Figure 3) (Silhavy et al., 2010). The outer 
membrane is asymmetrically composed of a lipopolysaccharide outer leaflet and a 
phospholipid inner leaflet, and the inner membrane is composed of a phospholipid bilayer 






 Schematic of the Gram-negative bacterial membrane. Figure 3.
The Gram-negative outer membrane is asymmetrically made up of outer leaflet 
lipopolysaccharide, containing an O-antigen chain anchored into the membrane by Lipid 
A, and inner leaflet phospholipids. Between the outer and inner membrane is the 
periplasmic region, containing a thin peptidoglycan layer. The bacterial inner membrane 







The outer leaflet of the S. flexneri outer membrane is made up of 
lipopolysaccharide (Clifton et al., 2013). The bacterial lipopolysaccharide is composed of 
a lipid A molecule embedded in the bacterial outer membrane, connected to an O-antigen 
chain that masks the surface of the bacteria (Kamio & Nikaido, 1976). The 
lipopolysaccharide molecules of bacteria are most notable for their endotoxic affect and 
for their ability to activate a TLR4 response during infection (Raetz et al., 2007). Both 
the O-antigen chain and Lipid A molecules play important roles in S. flexneri 
pathogenesis.  
The O-antigen chain of S. flexneri has been well characterized for its role in IcsA 
localization, while the role of the S. flexneri lipid A molecule in pathogenesis is less well 
understood. During pathogenesis, S. flexneri actively modifies the acylation state of its 
lipid A species during intracellular growth (Paciello et al., 2013). This phenotype has 
been observed in many Gram-negative bacteria and may help to evade the host immune 
response (Needham & Trent, 2013).  
In other cases, modifications to the Gram-negative lipid A molecules can help to 
provide a barrier against harsh environmental conditions (Giles et al., 2011), or to gain 
resistance against antimicrobial peptides (Hankins et al., 2012). In S. flexneri, a mutation 
of vpsC, a component of the Mla pathway (Malinverni & Silhavy, 2009), causes an 
accumulation of phospholipids in the outer leaflet of the outer membrane (Carpenter & 
Payne, 2014). PagP activation causes remodeling of the S. flexneri lipid A species from 
hexa-acylated to hepta-acylated to reduce the amount of outer leaflet phospholipids; 
however, this modification to lipid A reduces the outer membrane integrity of S. flexneri, 






Phospholipids make up the majority of S. flexneri’s membranes. The phospholipid 
bilayer makes up the bacterial inner membrane and the inner leaflet of the outer 
membrane. In general, relatively little is known of the role of specific phospholipids 
during bacterial pathogenesis, and their role in S. flexneri pathogenesis is unstudied.  
Previous studies in the S. flexneri-like bacterium E. coli have determined the 
phospholipid composition of Gram-negative bacteria (Figure 4). During growth in 
exponential phase, phosphatidylethanolamine (PE) is the major phospholipid in the 
membrane of E. coli, representing almost 80% of the total phospholipids (Pluschke et al., 
1978). The anionic phospholipids phosphatidylglycerol (PG) and cardiolipin account for 






 Schematic of E. coli cardiolipin synthesis. Figure 4.
In E. coli, cardiolipin (CL) is synthesized by the condensation of two 
phosphatidylglycerol (PG) molecules (clsA and clsB) (Guo & Tropp, 2000; Pluschke et 
al., 1978) or the condensation of one PG and one phosphatidylethanolamine (PE) 
molecule (clsC) (Tan et al., 2012). The chemical structures of PG, PE, and CL were 





3.3 ANIONIC PHOSPOLIPIDS HAVE UNIQUE CHARACTERISTICS. 
The anionic phospholipids of E. coli contain negatively charged glycerol head 
groups attached to phospho-glycerol molecules that connect two acyl chains. Anionic 
phospholipids tend to localize at the bacterial poles. Cardiolipin localizes to the bacterial 
pole (Figure 5), and phosphatidylglycerol localizes adjacent to cardiolipin (Oliver et al., 
2014). In the absence of cardiolipin, the anionic phospholipid phosphatidylglycerol, 
which shares the same glycerol head group as cardiolipin, will localize to the bacterial 
poles (Renner & Weibel, 2011) and interact (Renner & Weibel, 2012) with proteins in a 
similar manner as cardiolipin. 
Although anionic phospholipids only make up about 20% of the Gram-negative 
bacterial membrane, they are critical for maintaining the membrane structure. Anionic 
phospholipids are the point of attachment for the Braun lipoprotein, (Braun, 1975) a 
protein that connects the outer membrane to the inner membrane to prevent the outer 
membrane from sloughing away. Because of their unique localization and function, 
anionic phospholipids are thought to provide a mechanism for bacteria to localize 






 The misbalanced composition of cardiolipin allows it to localize at the Figure 5.
bacterial poles. 
Cardiolipin (CL) has a small glycerol head group connecting four large acyl 
chains. This gives cardiolipin a misbalanced composition and causes the destabilization 
of linear membranes. Cardiolipin, therefore, diffuses to the bacterial pole where regions 
of negative membrane curvature are found, in the inner leaflets of both the inner and 
outer membrane. In the region directly adjacent to the bacterial pole, 
phosphatidylglycerol (PG) is found, while phosphatidylethanolamine (PE) makes up the 






In E. coli, cardiolipin appears to localize at the poles of the bacterial inner leaflets 
in both the inner and outer membranes (Oliver et al., 2014). Cardiolipin is a large anionic 
glycerol phospholipid composed of four large acyl chains connected by a small glycerol 
head group (Mileykovskaya et al., 2005). The composition gives cardiolipin a conical 
shape that allows it to accumulate at membrane regions that have negative curvature 
(Figure 5) (Renner & Weibel, 2011). 
 
4.1 IDENTIFICATION OF CARDIOLIPIN. 
Cardiolipin was first identified in bovine cardiac tissue, which contains high 
proportions of mitochondria (Pangborn, 1945). Cardiolipin makes up the majority of the 
phospholipids found in the highly folded negative membrane curvature of the inner 
mitochondrial matrix and aids in the localization and activation of electron transport 
proteins (Mileykovskaya et al., 2005). Further analysis determined that cardiolipin helps 
to orient proteins for proper protein-protein interactions to shuttle electrons (Schenkel & 
Bakovic, 2014). 
 
4.2 ROLE IN BACTERIAL MEMBRANE. 
The functional characteristics of cardiolipin observed in the inner mitochondrial 
membrane have also been observed in the plasma membrane of E. coli. Here, cardiolipin 
can also localize electron transport proteins for their activation (Yankovskaya et al., 
2003). In addition, cardiolipin has also been implicated in the osmotic stress response of 
both Gram-negative and Gram-positive bacteria (Koprivnjak et al., 2011; Lin et al., 2015; 




cardiolipin aids in localizing osmotic transport proteins within the plasma membrane 
(Romantsov et al., 2009). Cardiolipin has also been shown to be important for the 
localization and activation of proteins required for cell division (Hsieh et al., 2010). 
 
4.3 ROLE IN BACTERIAL PATHOGENESIS. 
Until recently, the role of cardiolipin in bacterial pathogenesis has been under 
studied. This is likely because most bacteria have three-cardiolipin synthases, so all three 
must be deleted to see a cardiolipin-associated phenotype. In addition, the absence of 
cardiolipin may be functionally compensated for by the other anionic phospholipid, 
phosphatidylglycerol. As a result, most bacteria that lack cardiolipin do not display an in 
vitro growth phenotype. 
In Moraxella catarrhalis, cardiolipin has been shown to be required for proper 
adherence to human epithelial cells (Buskirk & Lafontaine, 2014), suggesting that 
cardiolipin aids in the localization of adhesion proteins that are required for pathogenesis. 
In Salmonella enterica Typhimurium, PbgA transport cardiolipin to the outer membrane 
(Figure 6), and this is required for intracellular survival within macrophages (Dalebroux 
et al., 2015), suggesting that cardiolipin is required to maintain barrier integrity in the 
harsh environment of the phagosome. 






 Schematic of S. Typhimurium transport of cardiolipin to the outer Figure 6.
membrane. 
In S. Typhimurium, cardiolipin is transported to the bacterial outer membrane by 
PbgA (Dalebroux et al., 2015). In response to PhoPQ inducing conditions, expression of 
pbgA increases and PbgA oligomerizes within the bacterial inner membrane. This allows 
delivery of cardiolipin to the outer membrane, via the PbgA periplasmic domain. 
Removal of this C-terminal periplasmic domain inhibits cardiolipin transport. Figure 






5. Overview of S. flexneri IcsA 
S. flexneri, which is non-motile, uses actin-based propulsion to move through the 
host cell cytoplasm and protrude into the neighboring cell. Actin-based motility requires 
proper localization of the virulence protein IcsA to one pole on the bacterial surface 
(Goldberg et al., 1993; 1994). During invasion, IcsA contributes to bacterial uptake by 
aiding in the adhesion of the bacteria to the host epithelial cell (Brotcke Zumsteg et al., 
2014). Once inside the host cell cytoplasm, IcsA is responsible for the recruitment of 
neural Wiskott-Aldrich syndrome protein (N-WASP) found in the host cell cytosol (Egile 
et al., 1999; Suzuki et al., 2002). N-WASP then recruits Arp2/3, activating actin-based 
motility. IcsA mutants are invasive and replicate within epithelial cells but cannot spread 
to adjacent cells (Bernardini et al., 1989).  
IcsA is a member of the auto-transport protein family (Figure 7A) (Kühnel & 
Diezmann, 2011). It contains an N-terminal signal sequence that allows for secretion 
from the cytoplasm to the periplasm (Suzuki et al., 1995). Adjacent to the secretion 
signal is a passenger domain. This domain contains functional domains of IcsA including 
the following: the N-WASP recruitment domain (Teh & Morona, 2013), polar targeting 
(PT) domain (Charles et al., 2001), passenger-associated transport repeats (Doyle et al., 
2015c), and IcsP cleavage site (Fukuda et al., 1995). The C-terminal domain contains the 
beta-barrel (Leyton et al., 2012), which integrates into the bacterial outer membrane for 
passenger domain surface exposure. 
Translation of IcsA occurs in the cytoplasm, and its N-terminal signal sequence 
directs IcsA secretion into the periplasm through the inner membrane Sec system (Figure 




cleaved. Once in the periplasm, IcsA transitions to the outer membrane where the C-
terminal beta-barrel then inserts into the outer membrane. Rapid auto-transport of the 
IcsA passenger domain then occurs, exposing the passenger domain to the outside of the 
bacterial cell. 
The localization of IcsA on the surface of S. flexneri is to the old pole of the 
bacterial cell (Goldberg et al., 1993); however, the mechanism for unipolar targeting of 






 Schematic of S. flexneri IcsA. Figure 7.
(A) IcsA contains two major domains. At the N-terminus is the passenger domain, 
containing the secretion signal sequence, N-WASP recruitment domain, and domain 
required for polar targeting of IcsA. The C-terminus contains the beta-barrel domain, 
which is inserted into the bacterial outer membrane and allows for auto-transport and 
extracellular exposure of the passenger domain. Figure adapted from Doyle et al. 
(2015a). (B) IcsA is transcribed in the cytoplasm and secreted into the periplasm via the 
inner membrane Sec system. Once in the periplasm, the IcsA beta-barrel inserts into the 
outer membrane, followed by rapid auto-transport of the passenger domain for 





6. Mechanisms for IcsA localization 
 
6.1 ROLE OF CHAPERONE PROTEINS IN ICSA LOCALIZATION. 
During its translation in the cytoplasm and secretion to the periplasm, the IcsA 
beta-barrel remains in a folded conformation (Brandon & Goldberg, 2001); however, the 
passenger domain remains unfolded in the cytoplasm and becomes properly folded in the 
periplasm. Cytoplasmic chaperone proteins, such as DnaK (Janakiraman et al., 2009) and 
YidC (Gray et al., 2014), help IcsA remain in the proper conformation in the cytoplasm 
to facilitate periplasmic secretion. DnaK itself localizes to the bacterial pole and 
facilitates secretion of IcsA to the periplasm at the bacterial pole (Janakiraman et al., 
2009). 
Once in the periplasm, the beta-barrel of IcsA must remain folded, and the 
passenger domain of IcsA must become properly folded (Brandon & Goldberg, 2001). 
Periplasmic chaperone proteins DegP, Skp, and SurA have been shown to be required for 
unipolar surface localization of IcsA (Purdy et al., 2002; 2007). This suggests that these 
chaperone proteins aid in the periplasmic folding of IcsA or targeting of IcsA to the 
bacterial pole for outer membrane insertion and auto-transport. 
 
6.2 ROLE OF O-ANTIGEN IN ICSA LOCALIZATION. 
Lipopolysaccharide is the major component of the S. flexneri outer membrane 
(Kenne et al., 1978). The O-antigen polysaccharide chain that is connected to the lipid A 
region of the S. flexneri lipopolysaccharide is responsible for providing a smooth 
bacterial surface (Simmons & Romanowska, 1987). The O-antigen chain length of S. 




1992). Early studies showed that S. flexneri rough mutations that lack the O-antigen chain 
of the lipopolysaccharide are associated with disruption of IcsA localization (Hong & 
Payne, 1997; Morona et al., 1995); however, the mechanism is unknown. 
One model suggests that the presence of O-antigen can affect the membrane 
fluidity of the bacterial outer membrane. In the presence of O-antigen, the membrane 
fluidity is low, resulting in less IcsA diffusion from the bacterial pole (Robbins et al., 
2001). In the absence of O-antigen, the membrane fluidity is high, increasing IcsA 
diffusion from the bacterial pole. An alternative model for O-antigen directing IcsA polar 
localization suggest localization of IcsA is dependent on the spatial localization of short 
and long O-antigen. An increase in O-antigen length, observed at the non-polar regions of 
the bacteria, could shield IcsA to inhibit its function (Morona & Van Den Bosch, 2003), 
whereas a decrease in O-antigen chain length, observed at the bacterial pole, could 
unmask IcsA for proper function (Sandlin et al., 1995). 
A more recent study showed that IcsA polarity and surface diffusion is not 
affected by O-antigen composition (Doyle et al., 2015a). In addition, they showed that O-
antigen chain length are symmetrical across the bacterial surface, therefore IcsA masking 
is symmetrical. This has lead to a more recent model suggesting that O-antigen synthesis 







6.3 ROLE OF OUTER MEMBRANE PROTEINS IN ICSA LOCALIZATION. 
 
6.3.1 IcsP. 
The major S. flexneri outer membrane protease, IcsP, is required for cleavage of 
surface exposed IcsA. (Shere et al., 1997). Located near the C-terminal portion of the 
IcsA passenger domain is an IcsP cleavage site (Shere et al., 1997). This cleavage 
mediates the turnover of IcsA from an active to inactive form by releasing the 95-kD N-
terminal domain of IcsA. Interestingly, the localization of IcsP is opposite to that of S. 
flexneri IcsA (Tran et al., 2013), where IcsP localizes to the bacterial septum which 
becomes the new pole. This suggests that IcsP controls unipolar exposure of the IcsA N-
WASP recruitment domain by cleaving IcsA that is exposed at the new pole of S. 
flexneri. 
Polar localization of IcsA when expressed in bacteria that lack characterized S. 
flexneri systems thought to be involved in IcsA localization, such as IcsP (Robbins et al., 
2001; Tran et al., 2013), still have a large proportion of polar localized IcsA, suggesting 
intrinsic protein properties of IcsA cause polar localization. 
 
6.3.2 OmpA and PhoN2. 
The major outer membrane protein of S. flexneri, OmpA, which is 
circumferentially localized, has been shown to play a role in IcsA localization (Ambrosi 
et al., 2012). In the absence of OmpA, IcsA is exposed uniformly across the bacterial 
surface; however, actin tails are still produced. Further studies revealed that the S. 
flexneri OmpA is found in two conformations, and it was hypothesized that polar OmpA 




Recently, the periplasmic apyrase protein, PhoN2 (Santapaola et al., 2006), has 
been shown to localize to the bacterial pole and interact with OmpA but not IcsA 
(Scribano et al., 2014; 2016). In addition, targeting of PhoN2 was independent of OmpA, 
and polar conformation of OmpA disappeared in the absence of PhoN2. This suggests 
that the interaction between of PhoN2 on OmpA keeps OmpA in its polar conformation 
and results in IcsA exposure. However, the mechanism PhoN2 uses to localize to the 
bacterial pole is unknown. 
 
6.4 ROLE OF ICSA POLAR TARGETING DOMAIN IN ICSA LOCALIZATION. 
Intrinsic polar targeting domains have been identified within IcsA (Figure 8A). 
For example, the N-terminal (IcsA 1-104) and central (IcsA 507-620) polar targeting 
regions (Charles et al., 2001), when fused to fluorescent proteins, are able to direct 
fluorescence to the poles of S. flexneri and other Gram-negative bacteria (Doyle et al., 
2015b; Janakiraman et al., 2009). Because these IcsA fusion proteins do not contain the 
N-terminal secretion domain of IcsA, it suggests these domains can target IcsA to the 
pole independent of periplasmic secretion, suggesting a conserved method for polar 
targeting between the inner and outer membrane.  
Mutational analysis of the central polar targeting domain for residues that disrupt 
polar targeting reveled two residue “hot-spot” areas (HS1 - IcsA 522-535 and HS2 – 
IcsA562-567) (Doyle et al., 2015b; May & Morona, 2008). Further analysis of these 
mutants revealed that polar targeting, in most mutants, was affected because of reduced 
IcsA levels. This suggest that these mutations are affecting the stability of IcsA, not polar 




targeting of IcsA, and this effect was independent of IcsA protein levels suggesting 
Arg564 plays a role in bringing IcsA to the bacterial pole. 
Recently, the crystal structure of the IcsA passenger domain was resolved 
(Leupold et al., 2017), providing insight into the role of each polar targeting domain 
mutation on the IcsA structure. The structural characteristics of the IcsA passenger 
domain containing the central polar targeting domain are consistent with a beta-helix. 
Residues in the HS2 domain, required for IcsA polar targeting, are required to maintain 
the hydrophobic core of the beta-helix. Mutations in these residues are predicted to lead 
to protein instability and reduced levels of IcsA. Interestingly, IcsA-Arg564 was found to 
be an exposed residue in the HS2 domain, and a mutation in this residue is not predicted 
to alter the stability of the hydrophobic core. Together, these data suggest that IcsA-






 IcsA-Arg564 is critical for IcsA polar targeting. Figure 8.
 (A) IcsA is an auto-transport protein. It contains an N-terminal signal peptide 
(SP), a passenger domain that consists of a polar targeting region (PT), and a C-terminal 
beta-barrel transmembrane domain. Figure adapted from Leupold et al. (2017). (B) 
Residues in Hot Spot 2 (H2) are required for polar targeting of IcsA. IcsA-Arg564 in H2 
is exposed and critical for polar targeting, independent of IcsA structure. Figure adapted 





7. Purpose of this research 
Worldwide, Shigella spp. infect hundreds of millions of people annually, with 
fatality rates up to 15%. Increasing antibiotic resistance between Shigella isolates 
compromises treatment of shigellosis, and there is no approved vaccine to prevent future 
infection. This has created a growing need to understand the molecular mechanism 
Shigella uses to cause disease and to identify therapeutic targets to treat and prevent 
future Shigella infections. 
To cause disease, S. flexneri must encode the tools necessary to invade colonic 
epithelial cells, then replicate and move within host cell cytoplasm, and then spread 
intercellularly. Genes encoded on a large virulence plasmid have been well characterized 
for their role in S. flexneri pathogenesis; however, many chromosomally encoded genes, 
that are not required for in vitro growth, remain uncharacterized. This study examines the 
role of S. flexneri phospholipid composition in pathogenesis. 
In this study I have established that cardiolipin is required for S. flexneri 
pathogenesis, although cardiolipin only makes up 7% of S. flexneri phospholipids. I 
determined that clsA encodes the major cardiolipin synthase, and pbgA encodes the 
phospholipid transporter in S. flexneri. Both of these genes were required for S. flexneri 
plaque formation but acted at different points in the virulence pathway. I determined that 
S. flexneri requires cardiolipin in the inner membrane for proper intracellular division, 
and outer membrane cardiolipin is required for unipolar localization of the actin 
polymerization protein IcsA. 
This study contributes to our understanding of the intracellular lifestyle of S. 




contributes to our understanding of the role of phospholipids, specifically cardiolipin, 
during bacterial pathogenesis. The lack of an in vitro phenotype displayed by cardiolipin 
deficient bacteria has caused it to be overlooked. This study should encourage re-
examination of cardiolipin in other bacteria, as its synthesis and outer membrane 





II. MATERIALS AND METHODS 
 
1. Bacterial Media and Growth Conditions 
All strains were maintained at -80°C in Tryptic Soy Broth (TSB) containing 20% 
(v/v) glycerol. E. coli strains were grown on Luria-Bertani (LB) agar (1% tryptone, 0.5% 
yeast extract, 1% NaCl, 1.5% agar [w/v]) at 37°C, and single colonies were selected and 
grown in LB broth at 37°C. S. flexneri strains were grown on TSB agar (TSB, 1.5% agar 
[w/v]) containing Congo red dye (0.01% [w/v]; Sigma) at 37°C. Congo red binding 
colonies (Payne & Finkelstein, 1977), indicating a functional T3SS, were selected and 
grown in LB broth at 30°C for maintenance, and were then subcultured 1:100 and grown 
at 37°C for assays. Antibiotics were used at the following concentrations: kanamycin, 50 





2. DNA Techniques 
 
2.1 DNA ISOLATION. 
 
2.1.1 Chromosomal. 
Bacterial chromosomes were isolated from 1.0 ml of overnight culture using the 
Invitrogen PureLink Genomic DNA kit. Chromosomes were stored in double distilled 
water (ddH2O) at -20°C. 
 
2.1.2 Plasmid. 
Bacterial plasmids were isolated from 5.0 mls of overnight culture using the 
Sigma- Aldrich GenElute Plasmid Miniprep kit. Plasmids were stored in ddH2O at -20 °C. 
 
2.2 POLYMERASE CHAIN REACTION. 
Primers used in this study are listed in Table 1. 
 
2.2.1 Amplification. 
DNA amplifications were carried out using either Novagen KOD Hot Start DNA 
Polymerase High-Fidelity or New England Biolabs Phusion High-Fidelity DNA 
Polymerase. Templates used were either purified chromosomal DNA or plasmid DNA, at 




For KOD, standard reaction conditions were used with an initial denaturing step 
at 95 °C for 2 min. This was followed by 30 cycles of: denaturing at 95 °C for 20 sec, 
annealing at varying temperatures depending on primers between 55 °C and 65 °C for 10 
sec, and extension at 70 °C with varying extension times at 30 sec per kb depending on 
product length. Reaction was finished with a final 5 min extension at 70 °C and held at 4 
°C until further use. 
For Phusion standard reaction conditions were used with an initial denaturing step 
at 98 °C for 30 sec. This was followed by 30 cycles of: denaturing at 98 °C for 10 sec, 
annealing at varying temperatures depending on primers between 55 °C and 65 °C for 30 
sec, and extension at 72 °C with varying extension times at 30 sec per kb depending on 
product length. Reaction was finished with a final 5 min extension at 72 °C and held at 4 
°C until further use. 
 
2.2.2 Screening. 
To confirm proper chromosomal manipulation or plasmid construction, colony 
PCR was performed using New England Biolabs Taq DNA Polymerase. Standard 
reaction were used with an initial denaturing step at 98 °C for 30 sec. This was followed 
by 30 cycles of: denaturing at 95 °C for 30 sec, annealing at varying temperatures 
depending on primers between 55 °C and 65 °C for 30 sec, and extension at 68 °C with 
varying extension times of 1 min per kb depending on product length. Reaction was 
finished with a final 5 min extension at 68 °C and held at 4 °C until further use. Bacterial 






2.2.3 Site-directed Mutagenesis. 
Amino acid substitutions in expression plasmids were made using the Agilent 
Technologies, Inc. QuikChange protocol. Overlapping primers were designed to 
introduce a single codon substitution during PCR amplification. PCR reactions were 
carried out using the New England Biolabs Phusion High-Fidelity DNA Polymerase 
protocol. Standard reaction used (see above). After amplification, the product was treated 





Table 1. Primers used in this study. 








































2.3 PLASMID CONSTRUCTION. 
Plasmids used in this study are listed in Table 2. Constructed plasmids were 
sequenced at the University of Texas at Austin DNA sequencing facility using an ABI 




A plasmid expressing clsA was constructed by amplifying the wild-type locus 
containing the native promoter region from S. flexneri strain 2457T and ligating the PCR 
product into the SmaI site of pWKS30 (Wang & Kushner, 1991). Primers clsA-F and 




A plasmid expressing pbgA was constructed by amplifying the wild-type locus 
containing the native promoter region from S. flexneri strain 2457T and ligating the PCR 
product into the SmaI site of pWKS30 (Wang & Kushner, 1991). Primers pbgA-F and 




A plasmid expressing icsA-502-620 with C-terminal gfp was constructed by 




502-F and IcsA-620-R, and then amplifying the gfp locus from pVES143 using primers 
GFP-F and GFP-R. Overlap PCR was then performed to produce a single fragment using 
individual icsA and gfp fragments as template and primers IcsA-502-F and GFP-R. The 
final PCR product was ligated into the SmaI site of pWKS30 (Wang & Kushner, 1991). 
 
2.3.4 picsA-His. 
A plasmid expressing icsA-417-758 with a N-terminal 6xHis tag was constructed 
by amplifying the wild-type locus from S. flexneri strain 2457T using primers IcsA-419-F 




A plasmid expressing icsA-419-758 with a N-terminal 6xHis tag and with Arg564 
of icsA substituted to an Ala, was constructed by performing a quick change reaction on 





Table 2. Plasmids used in this study. 
Plasmids Description Reference 
pKD4 kan cassette template (Datsenko & Wanner, 2000) 
pKD46 Ts Red recombinase (Datsenko & Wanner, 2000) 
pCP20 Ts Flp recombinase 
(Cherepanov & 
Wackernagel, 1995) 
pWKS30 Low-copy expression vector (Wang & Kushner, 1991) 
pET16b 
N-term His with TEV protein 
purification vector 
Novagen 
pVES143 GFP template vector (Waters et al., 2008) 
pclsA clsA in pWKS30 This study 
ppbgA pbgA in pWKS30 This study 
pcfp cfp-expressing plasmid (Dragoi & Agaisse, 2014) 
pyfp yfp-expressing plasmid (Dragoi & Agaisse, 2014) 
picsA-His 
icsA amino acids 419 -758 in pET16b 
with N-terminal His tag and TEV site 




icsA amino acids 419 -758 in pET16b 






Table 2 (continued). 
 with Arg 546 substituted to Ala  
picsA-gfp 
icsA amino acids 502-620 with C-
terminal GFP fusion in pWKS30 







3. Construction of Bacterial Strains 
Strains used in this study are listed in Table 3. All mutations were verified via 
colony PCR. 
 
3.1 TRANSFORMATION OF E. COLI. 
CaCl2-competent Top 10 E. coli cells were used for plasmid construction and 
maintenance by heat-shock transformation. Competent E. coli cells were prepared from 
mid-log (OD650 ~ 0.4) cultures. The cultures were chilled and then pelleted at 4°C. The 
cells were washed with ice-cold CaCl2 solution (60 mM CaCl2, 10 mM PIPES at pH 7.0, 
and 15% glycerol) and then incubated overnight in fresh CaCl2 solution at 4°C. The cells 
were then pelleted at 4°C and resuspended in fresh CaCl2 solution (concentrated 100X 
from culture volume) and divvied into 100 μl aliquots and stored at -80°C. 
Transformations were carried out by thawing cells on ice, followed by an 
additional ice incubation with plasmid DNA for 20 min. Cells were then heat shocked at 
42°C for 45 seconds, chilled on ice for 2 min and incubated with 750 μl of LB for 1 hour 
at 37°C. Bacteria were then plated on LB agar supplemented with antibiotics. 
 
3.2 P1 TRANSDUCTION. 
S. flexneri chromosomal mutations were generated by bacteriophage P1 
transduction from E. coli. P1 bacteriophage stocks were maintained and titered on E. coli 
strain W3110 in LB soft agar (LB containing 0.75% agar and 5 mM CaCl2), containing 1 
mM dithiotreitol (DTT). E. coli donor strains (Baba et al., 2006) were grown in LB 




pfu/ml P1 stock was added to soft agar, overlaid onto LB agar and incubated at 37°C. 
Upon lysis of the bacterial lawn, the P1 was harvested by adding 2ml LB, containing 5 
mM CaCl2, to the soft agar, for collection, and a few drops of chloroform. The soft 
agar/chloroform mixture was vortexed for 1 min, and cell debris was pelleted. P1 donor 
supernatant were collected and stored at 4°C with chloroform. P1 donor was titered prior 
to recipient transduction. 
Recipient S. flexneri strains were grown in LB containing 5 mM CaCl2 to mid-log 
(OD650 ~ 0.4) and 100μl of 1x108 pfu/ml P1 donor was added to 1 ml of recipient culture 
and incubated at 37°C for 1 hour. Cells were then pelleted, resuspended in LB containing 
50 mM Na-citrate, and incubated at 37°C for 1 hour. S. flexneri recipients were then 
plated on TSB agar containing antibiotics. 
 
3.3 ELECTROPORATION. 
Electroporation was used to transform plasmid DNA into S. flexneri. 
Electrocompetent Shigella were prepared from mid-log (OD650 ~ 0.4) cultures. The 
cultures were pelleted and washed twice with ice cold G-buffer (137 mM sucrose, 1 mM 
HEPES, pH 8). The cultures were then resuspended into 500μl of G-buffer and 
transferred into cold electroporation cuvettes (BioRad). Plasmid DNA was added and S. 
flexneri was electroporated using a GenePulse electroporator (BioRad) with the following 
settings; 200 Ω, 25 mF, and 2.5 V. Bacteria were then incubated in 750μl of LB for 1 





3.4 CONSTRUCTION OF S. FLEXNERI STRAINS. 
 
3.4.1 clsA. 
The S. flexneri clsA mutant was created by bacteriophage P1 transduction of the 
ΔclsA:kan allele from E. coli strain JW1241 (Keio Collection) into S. flexneri 2457T 2a 
(Baba et al., 2006). 
 
3.4.2 clsB. 
The S. flexneri clsB mutant was created by bacteriophage P1 transduction of the 
ΔclsB:kan allele from E. coli strain JW0772 (Keio Collection) into S. flexneri 2457T 2a 
(Baba et al., 2006). 
 
3.4.3 clsC. 
The S. flexneri clsC mutant was created by bacteriophage P1 transduction of the 
ΔclsC:kan allele from E. coli strain JW5150 (Keio Collection) into S. flexneri 2457T 2a 
(Baba et al., 2006). 
 
3.4.4 clsA, clsB, and clsC double and triple mutants. 
Double and triple mutants were created using a multi-step procedure where by the 
kanamycin resistance cassette used to create an existing mutation was removed using the 
plasmid pCP20 (Cherepanov & Wackernagel, 1995), followed by P1 transduction to 






The S. flexneri pbgA mutant was created using λ-Red-mediated recombination 
(Datsenko & Wanner, 2000). A PCR product was generated by amplifying the kanamycin 
resistance cassette from pKD4 using primers pbgA-KO-F and pbgA-KO-R, which 
modified the wild-type pbgA gene by introducing a UGA termination codon in place of 
the codon for Y190 and replaced the downstream codons with a kanamycin resistance 
cassette (Datsenko & Wanner, 2000; De Lay & Cronan, 2008). This PCR product was 
introduced by electroporation into E. coli strain BW25113 expressing λ-Red-recombinase 
from plasmid pKD46 (Datsenko & Wanner, 2000), and recombinants were selected by 
kanamycin resistance. This mutation was then introduced into S. flexneri through 





Table 3. Strains used in this study. 
Strain Description Reference 
E. coli   
Top10 Cloning strain Thermo Fisher Scientific 
W3110 Wild Type (Oliver et al., 2014) 
BL 21 DE3 Protein purification strain New England Biosciences 
BW25113 Wild Type (Datsenko & Wanner, 2000) 
JW1241 BW25113 Δcls::kan 
Keio Collection (Baba et al., 
2006) 
JW0772 BW25113 ΔybhO::kan 
Keio Collection (Baba et al., 
2006) 
JW5150 BW25113 ΔymdC::kan 
Keio Collection (Baba et al., 
2006) 
JW3160 BW25113 ΔmlaD::kan 
Keio Collection (Baba et al., 
2006) 
E.C.-pbgA BW25113 ΔyejM190-586::kan 
This study (De Lay & 
Cronan, 2008) 






Table 3 (continued). 
WT 
2457T Wild Type, serotype 2a 
(AE014073.1)a 
Walter Reed Army Institute 
of Research (Wei et al., 
2003) 
clsA 2457T Δcls::kan (AAP16748.1) This study 
clsB 2457T ΔybhO::kan (AAP16251.1) This study 
clsC 2457T ΔymdC::kan (AAP16548.1) This study 
clsAB 2457T Δcls::FRT, ΔybhO::kan This study 
clsAC 2457T Δcls::FRT, ΔymdC::kan This study 
clsBC 2457T ΔymdC::FRT, ΔybhO::kan This study 
clsABC 







icsA 2457T icsA::E2-Tn5 (AAL72293.1) H. Marman 
vpsC 2457T, ΔvpsC::kan (AAP18513.1) 
This study (Carpenter et al., 
2014) 
rol SA100, serotype 2a Δrol::kan (Hong & Payne, 1997) 




4. RNA Techniques 
 
4.1 IN VITRO S. FLEXNERI RNA ISOLATION. 
CR+ colonies were grown overnight at 30°C in LB with aeration and then diluted 
1:100 into LB+ 0.01% Sodium deoxycholate (DOC) and grown at 37°C with aeration to 
an OD650 of ~ 0.7. Using RNA-Bee (Tel-Test, Inc.), RNA was harvested from the cells 
followed by DNas I (Life Technologies) treatment to remove genomic DNA. 
 
4.2 IN VIVO S. FLEXNERI RNA ISOLATION. 
Intracellular RNA was isolated by infecting semiconfluent Henle-407 monolayers 
with approximately 108 CFU grown to midlog in LB + 0.01% DOC. At 4 hours post-
infection monolayers were treated with RNA-BEE and treated in an identical manner as 
described above. 
 
4.3 AMPLIFICATION OF CDNA. 
cDNA was generated using Superscript III reverse transcriptase (Life 
Technologies) with 2 μg of RNA as cDNA template. 
 
4.4 QUANTITATIVE PCR. 
Power SYBR Green (Life Technologies) chemistry was used to amplify and 
detect targets. All probes were designed using Primer Express software (Applied 




name. cDNA was diluted 1:100 for detection by probes. Analysis was performed using an 
Applied Biosystems 7300 Real Time PCR system and software. Threshold cycle (CT) 






Table 4. Primers for quantitative PCR. 
















5. Cell Culture Techniques 
 
5.1 MEDIA AND GROWTH CONDITIONS. 
Henle cells (intestine 407; ATCC CCL-6), were cultured in minimal essential 
medium (MEM) (Gibco) containing: 10% (v/v) heat-inactivated fetal bovine serum (FBS) 
(Gibco); 10% (w/v) Bacto tryptone phosphate broth (Difco); 1X nonessential amino acids 
(Gibco); 2 mM glutamine. Colorectal cells (HT-29; ATCC HTB-38) were cultured in 
McCoy’s 5A medium (Gibco) supplemented with 10% (v/v) heat-inactivated FBS 
(Invitrogen). Henle and HT-29 cells were incubated at 37°C with 95% air and 5% CO2. 
Gentamicin was used at a final concentration of 40 μg/ml. 
 
5.2 PLAQUE ASSAY. 
Plaque assays were performed as previously described (Oaks et al., 1985). 
Briefly, bacteria were grown to an OD650 of ~ 0.5. Approximately 104 CFU of bacteria were 
added to a confluent monolayer of Henle cells in 35 mm, 6-well, polystyrene plates 
(Corning) and centrifuged for 10 min at 1,000 X g. Plates were incubated for 60 min, and 
the monolayers were washed 4 times with phosphate-buffered saline (PBS-D) (1.98 g 
KCl, 8 g NaCl, 0.02 g KH2PO4, 1.39 g K2HPO4). The media was then replaced with MEM 
containing gentamicin and 0.45% (w/v) glucose, and plates were then incubated for 24 
hrs, after which the medium was replaced with MEM containing only gentamicin, and 
plates were incubated for an additional 48 hrs. Monolayers were washed with PBS-D and 




5.3 INVASION ASSAY. 
Invasion assays were performed as previously described (Hale & Formal, 1981). 
Briefly, bacteria were grown to an OD650 of ~ 0.5. Approximately 108 CFU of bacteria were 
added to a semi-confluent monolayer of Henle cells in 35 mm, 6-well, polystyrene plates 
(Corning) and centrifuged for 10 min at 1,000 X g. Plates were incubated for 30 min and 
monolayers were washed 4 times with PBS-D. The media was replaced with MEM 
containing gentamycin, and the plates were incubated for an additional 40 min. 
Monolayers were washed with PBS-D and stained with Wright-Giemsa stain (Camco). 
Monolayers were visualized using bright-field microscopy at 1,000 X magnification. 
Henle cells were scored positive for invasion if they contained 3 or more S. flexneri cells. 
A total of 300 Henle cells per well were counted. 
 
5.4 INTRACELLULAR GROWTH RATES. 
Intracellular growth rates were measured by growing bacteria in LB containing 
0.1% DOC to an OD650 of ~ 0.5. Approximately 5 x 108 CFU of bacteria were added to a 
confluent monolayer of Henle cells in 22.1 mm, 12-well, polystyrene plates (Corning) 
and centrifuged for 10 min at 1,000 X g. Plates were then incubated for 30 min. 
Monolayers were then washed 4 times with PBS-D, and media was replaced with MEM 
containing gentamicin. Monolayers were washed with PBS-D after 60 min and 180 min, 
and lysed using 1.0% DOC. Lysates were diluted and plated on TSB agar, grown 
overnight at 37°C, and colonies were counted. The number of bacteria recovered at 60 





5.5 CELL-TO-CELL SPREAD. 
The analysis was performed as previously described (Carpenter et al., 2014). 
Briefly, bacteria were grown to an OD650 of ~ 0.5. Approximately 107 CFU of bacteria were 
added to a confluent monolayer of Henle cells in 35 mm, 6-well, polystyrene plates 
(Corning) and centrifuged for 10 min at 1,000 X g. Plates were incubated for 30 min and 
the monolayers were then washed 4 times with PBS-D. The media was replaced with 
MEM containing gentamicin and the plates were incubated for an additional 4 hrs. 
Monolayers were washed with PBS-D and stained with Wright-Giemsa stain. Henle cells 
were scored positive for spread if they contained 3 or more S. flexneri cells and if 






6. Fluorescence Microscopy Techniques 
 
6.1 SIZE OF INFECTED FOCI. 
The size of infection foci formed in plasma membrane-YFP-expressing HT-29 
cells grown in McCoy’s medium (Gibco, Life Technologies) and infected with the listed 
CFP-expressing S. flexneri strains was determined in a 96-well plate format (Corning, 
cat# 3904).  After fixation, plates were imaged using the ImageXpress Micro imaging 
system (Molecular Devices) and image analysis for foci size determination was 
performed with the ImageXpress imaging software (Molecular Devices) as previously 
described (Dragoi & Agaisse, 2014). 
 
6.2 MONITORING OF BACTERIA DISSEMINATION. 
Bacterial dissemination was monitored using time-lapse confocal microcopy. 
Plasma membrane-YFP-expressing HT-29 cells were grown in McCoy’s medium in 8-
well chambers (Lab-Tek II, cat# 155409, Thermo Fisher Scientific) at 37°C in 5% CO2. 
Cells were infected with the listed CFP-expressing S. flexneri strains and imaged with a 
Leica DMI 8 spinning-disc confocal microscope driven by the iQ software (Andor). Z-
stacks were captured 2 hours post-infection every 2 minutes for 6 hours. The 
corresponding movies were generated with the Imaris software (Bitplane). 
 
6.3 VISUALIZATION OF ICSA. 
IcsA was visualized as previously described (Purdy et al., 2007). Briefly, bacteria 




Cells were then labeled by indirect immunofluorescence, using rabbit polyclonal 
antibody against IcsA (Rabbit 35) diluted 1:100, provided by Edwin Oaks (Walter Reed 
Army Institute of Research), and a fluorescent isothiocyanate-conjugated goat anti-rabbit 
secondary antibody diluted 1:100 (Purdy et al., 2002). 
 
6.4 POLAR TARGETING OF ICSA. 
Polar targeting of IcsA was measured as previously described (Doyle et al., 
2015b). Bacteria expressing picsA-gfp were grown to mid-logarithmic phase and fixed in 





7. Lipid Techniques 
 
7.1 ISOLATION OF INNER AND OUTER MEMBRANES. 
Inner and outer membranes were isolated by pelleting mid-log bacteria at 13,000 
X g for 10 min, resuspending in buffer containing 10mM Na2HPO4, and 5mM MgSO4, 
sonicating to induce cell lysis, and centrifuging at 13,000 X g for 20 min to remove cell 
debris. The supernatant was then centrifuged at 135,000 X g for 40 min to isolate the total 
membranes. Total membranes were resuspended in 1.0% (w/v) Sarkosyl using a blunt 
needle and incubated at room temperature for 20 min. Following centrifugation at 
135,000 X g for 40 min, the inner membrane remained in the supernatant while the outer 
membranes were pelleted. The pelleted outer membranes were resuspended in fresh 1.0% 
(w/v) Sarkosyl and used for downstream assays. 
 
7.2 ISOLATION OF PHOSPHOLIPIDS. 
Bacteria were grown in LB to an OD650 of ~ 0.5 (mid-log), or as indicated. 
Phospholipids were extracted according to the method of Bligh and Dyer (Bligh & Dyer, 
1959). 
 
7.3 VISUALIZATION OF PHOSPHOLIPIDS. 
Phospholipids were spotted onto a Silica Gel 60 (Millipore) thin-layer 
chromatography (TLC) plate and separated by a chloroform-methanol-acetic acid 
(65:25:10, vol/vol) solvent system (Giles et al., 2011). Phospholipids were detected by 




phospholipid species was quantified using ImageJ software (Schneider et al., 2012) to 
determine the percentage of each phospholipid in the sample. 
 
7.4 DETECTION OF LIPOPOLYSACCHARIDES. 
The assay was performed as previously described (Tsai & Frasch, 1982). Briefly, 
bacteria were grown at 37°C to OD650 ~ 0.5, and the equivalent of OD650=1 was pelleted 
and resuspended in Laemmli SDS-PAGE sample buffer (Laemmli, 1970). Samples were 
then boiled for 10 min, cooled to room temperature, and treated with 25 μg proteinase K 
for 1 hour at 55°C. LPS was visualized by (4-12%) SDS-PAGE (Bolt Bis-Tris Plus, 
Invitrogen) and subsequent staining of the LPS with silver stain as follows; gels were 
fixed in 40% isopropanol and 5% acetic acid, oxidized with 0.7% periodic acid, stained 





8. Protein Techniques 
 
8.1 SDS-PAGE. 
Samples were resuspended in Laemmli SDS sample buffer (5% β-mercapto-
ethanol, 3% [wt/vol] SDS, 10% glycerol, 0.02 g bromophenol blue, 63 mM Tris-Cl, pH 
6.8) (Laemmli, 1970), and boiled for 5 min. Samples were electrophoresed in 
quadruplicate (10%) SDS-PAGE gels for separation. Proteins were visualized by 




Proteins were transferred to a 0.45 μm pore size nitrocellulose membrane (GE 
Healthcare) and incubated with either rabbit polyclonal anti-IcsA antibody (Edwin Oaks, 
Walter Reed Army Institute of Research) diluted 1:10,000, rabbit polyclonal anti-SecA 
antibody (Donald Oliver, Wesleyan University) diluted 1:10,000, rabbit polyclonal anti-
OmpA antibody (Donald Oliver, Wesleyan University) diluted 1:5,000, rabbit polyclonal 
anti-DegP (George Georgiou, The University of Texas at Austin) diluted 1:500, or mouse 
monoclonal anti-V5 antibody (Thermo Fisher Scientific) diluted 1:500. Proteins were 
detected using horseradish peroxidase-conjugated goat anti-rabbit antibody (diluted 
1:5,000). Signal was detected by developing the blot with a Pierce ECL detection Kit 





8.3 PURIFICATION OF ICSA. 
Purification was performed as previously described (Leupold et al., 2017). E. coli 
cells BL21DE3 expressing picsA-His or picsA-His-Arg564Ala were sub-cultured 1:100 
and grown in LB + ampicillin to mid-log phase at 37°C, induced with IPTG and grown 
for 5 hours at 25°C. Cells were then pelleted at 10,000 X g for 20 min at 4°C and washed 
with 150 mM NaCl. Bacterial pellets were stored at -80°C until protein purification.  
Thawed pellets were resuspended in lysis buffer (50 mM HEPES pH 7, 300 mM 
NaCl, 10 mM imidazole pH 7, 1% Triton X-100, 10% Glycerol, 5 mM β-mercapto-
ethanol and protease inhibitor [Roche]) and sonicated at 4°C. Lysates were then pelleted 
at 10,000 x g for 30 min at 4°C and the supernatant was added to a Ni-NTA Affinity 
Resin column (EMD Milipore) and incubated for 2 hours at 4°C. Using a gravity flow 
column, th resin was washed (50 mM HEPES pH 7, 300 mM NaCl, 30 mM imidazole pH 
7, 1% Triton X-100, and 5 mM β-mercapto-ethanol) with 50 column volumes, and 
proteins were eluted (50 mM HEPES pH 7, 300 mM NaCl, 250 mM imidazole, and 5 
mM β-mercapto-ethanol) in 2 column volumes. 
Elution fractions were analyzed by SDS-PAGE, and fractions containing protein 
were digested with TEV protease by adding 2% (w/w) to each elution fraction and 
incubating overnight at 4°C. Fractions were then pooled and concentrated using Amicon 
Ultra-15 30NMWL columns (EMD Millipore). Protein was buffer exchanged into storage 
buffer (50 mM HEPES pH 7, 150 mM NaCl) to a final concentration of 10 mg/ml and 





8.4 ICSA CO-SEDIMENTATION. 
Dried glycerolphospholipids (Cardiolipin, phosphatidylglycerol and 
phosphatidylethanolamine [Avanti Polar Lipids]) were resuspended in IcsA protein 
storage buffer (50 mM HEPES pH 7, 150 mM NaCl) to a final concentration of 1 mg/ml. 
Lipids were sonicated and vortexed to form a suspension. 10 μg of protein was incubated 
with 1 mg glycerolphospholipids for 1 hour at 37°C. The reactions were then centrifuged 
at 14,000 x g for 30 min, and supernatants and pellets were collected and Tricholoracetic 
Acid (TCA) precipitated. Precipitated fractions were resuspended in Laemmli SDS 
sample buffer for SDS-PAGE analysis. Proteins were visualized by Coomassie staining. 
The area of each protein species was quantified using ImageJ software (Schneider et al., 
2012) to determine the percentage of each protein in the sample. 
 
8.5 TRYPSIN CLEAVAGE OF ICSA. 
Trypsin cleavage of IcsA was performed as previously described (Besingi & 
Clark, 2015). Briefly, bacteria were grown to mid-logarithmic phase and equivalent cell 
numbers were divided (~8x108 cells), pelleted and were resuspended in Protease buffer 
(50 mM Tris pH 8.8, 7.5 mM CaCl2). Prior to digestion, one sample was sonicated to 
induce lysis. Trypsin (Sigma) was diluted to a final concentration of 10, 5, and 1 μg/ml 
and allowed to digest cell samples for 1 hour at 25°C. Samples were pelleted and 
resuspended in Laemmli SDS sample buffer for SDS-PAGE analysis. Proteins were 
visualized by Coomassie staining, and western blot analysis using anti-IcsA, anti-OmpA, 







1. Chapter 1: Characterization of Cardiolipin Synthesis and Transport1 
Cardiolipin is a large anionic phospholipid that localizes to the inner leaflet at the 
poles of Gram-negative bacteria. To characterize the mechanism S. flexneri uses to 
synthesize and transport cardiolipin, a series of mutants were constructed that disrupted 
one of the three putative inner membrane cardiolipin synthases, clsA, clsB, and clsC 
(Figure 4), or the transporter, pbgA (Figure 6). 
 
1.1 S. FLEXNERI CARDIOLIPIN IS SYNTHESIZED PRIMARILY BY CLSA. 
In E. coli, cardiolipin is synthesized by clsA, clsB, and clsC, which either 
condense two phosphatidylglycerol molecules (clsA and clsB) ) (Guo & Tropp, 2000; 
Pluschke et al., 1978) or condense phosphatidylglycerol and phosphatidylethanolamine 
molecules (clsC) (Tan et al., 2012), to produce cardiolipin (Figure 4). S. flexneri’s 
genome contains the genes cls, ybhO, and ymdC with homology to E. coli clsA, clsB, and 
clsC, respectively, which we have re-named to match the E. coli gene nomenclature. To 
determine the contribution of each predicted S. flexneri cardiolipin synthase, we 
constructed individual deletion mutants and examined their phospholipid composition 
using the Bligh-Dyer phospholipid isolation technique and subsequent TLC separation 
for visualization (Bligh & Dyer, 1959). When compared to WT, deletion of clsA resulted 
in the loss of detectable cardiolipin and a small increase in the level of 
                                                
1 Portions of this work have been previously published in mBio (Rossi, R. M., Yum, L., Agaisse, H. & 
Payne, S. M. (2017). Cardiolipin Synthesis and Outer Membrane Localization Are Required for Shigella 
flexneri Virulence. mBio 8, e01199–17.) by the American Society for Microbiology. R. M. Rossi designed 




phosphatidylglycerol in the membrane of S. flexneri during exponential growth (Figure 
9). The synthesis of cardiolipin was restored by introducing wild type clsA on a plasmid. 
Complementation with clsA also reduced PG levels to wild type. In contrast, the deletion 
of clsB and clsC had no detectable effect on cardiolipin levels under these conditions. 






 ClsA is the major cardiolipin synthase of S. flexneri. Figure 9.
TLC analysis of total S. flexneri membrane phospholipids of the wild type (WT) 
and cardiolipin synthesis mutants. Bacteria were grown to mid-log phase, and 
phospholipids were extracted and separated by TLC. The percentage of cardiolipin in the 
sample is indicted above each lane. Phospholipids were visualized using molybdenum 
blue spray (Sigma). The phospholipids include phosphatidylethanolamine (PE) 
phosphatidylglycerol (PG), and cardiolipin (CL). pclsA, plasmid expressing clsA. Figure 





1.2 CLSC CONTRIBUTES TO S. FLEXNERI CARDIOLIPIN SYNTHESIS IN STATIONARY 
PHASE. 
Previous studies have shown that E. coli produces higher levels of cardiolipin 
during growth in stationary phase (Hiraoka et al., 1993). To determine if S. flexneri also 
increases the amount of cardiolipin during stationary phase, we extracted and separated 
phospholipids from S. flexneri grown to stationary phase. We found the proportion of 
cardiolipin in S. flexneri’s membrane slightly increased in stationary phase (Figure 10). 
Interestingly, the clsA mutant showed detectable levels of cardiolipin during stationary 
phase growth, indicating an additional cardiolipin synthase(s) is active. To determine 
which cardiolipin synthase is active during stationary growth, we assessed the 
phospholipid levels in the cardiolipin synthase double mutants and found that the clsA 
clsC double mutant did not contain cardiolipin within its membrane during stationary 







 Cardiolipin synthesis increases during stationary phase growth. Figure 10.
Bacteria were grown into stationary phase (OD650 of ~2.0); phospholipids were 
then extracted and separated by TLC. The percentages of cardiolipin in the sample are 
indicated above each lane. Phospholipids were visualized using molybdenum blue spray 
(Sigma). The phospholipids include phosphatidylethanolamine (PE), 





1.3 CARDIOLIPIN LOCALIZES TO BOTH THE INNER AND OUTER MEMBRANES OF S. 
FLEXNERI. 
In Gram-negative bacteria, phospholipids are the major lipid components of the 
entire inner membrane and the inner leaflet of outer membrane. To determine if 
cardiolipin is found in both the inner and outer membranes of S. flexneri, we fractionated 
the inner and outer membranes using Sarkosyl solubilization and assessed their 
phospholipid composition by thin layer chromatography. Cardiolipin was found in both 
the inner and outer membranes of S. flexneri (Figure 11A), and the phospholipid 
distribution between the inner and outer membranes was similar. To confirm clean 
separation of the inner and outer membrane, samples of cell fractions were analysed by 
SDS-PAGE and Western blotting; the inner membrane protein SecA was not detected in 
the outer membrane fractions, and the outer membrane protein OmpA was only found in 
the outer membrane fractions (Figure 11B). 
 In addition, we fractionated the inner and outer membrane of the clsA mutant 
and found that the inner and outer phospholipid distributions look similar; however, both 
had increased levels of phosphatidylglycerol and no detectable cardiolipin, when 
compared to WT. The wild type levels of cardiolipin and PG and localization of 
cardiolipin to both the inner and outer membranes, was restored by complementation 
with clsA on a plasmid. This suggests that S. flexneri maintains equivalent phospholipid 






  S. flexneri requires pbgA for localization of cardiolipin to its outer Figure 11.
membrane. 
TLC analysis of S. flexneri inner and outer membrane phospholipids. (A) Inner 
and outer membrane composition analysis of pbgA and clsA mutants. Bacteria were 
grown to mid-log phase, and bacterial membranes were separated by solubilization in 
Sarkosyl. The phospholipids were then extracted, spotted for separation by TLC, and 
visualized using molybdenum blue spray reagent (Sigma). The phospholipids include 
phosphatidylglycerol (PG), phosphatidylethanolamine (PE), and cardiolipin (CL). The 
percentage of anionic phospholipids (AL) in the sample is indicated above each lane, and 
the means and standard deviations of three experiments are shown. The value that is 
significantly different (P < 0.05) from the value for the outer membrane of the wild type 




membrane fractions. Bacteria were grown to mid-log phase, and the bacterial membranes 
were separated by solubilization using Sarkosyl. Proteins were resolved by (10%) SDS-
PAGE and stained with Coomassie blue (CB) or immunoblotted using either polyclonal 
anti-SecA or polyclonal anti-OmpA. The molecular masses (in kilodaltons) of molecular 
mass markers are shown to the left of the gels. ppbgA, plasmid expressing pbgA; C, 






1.4 CARDIOLIPIN IS TRANSPORTED TO S. FLEXNERI OUTER MEMBRANE BY PBGA. 
In S. Typhimurium, activation of PhoPQ induces the expression of pbgA, which 
increases outer membrane integrity by transporting cardiolipin to the outer membrane 
(Figure 6) (Dalebroux et al., 2015). Complete deletion of pbgA in E. coli and S. 
Typhimurium is lethal; however, deletion of the C-terminal periplasmic portion reduced 
cardiolipin transport to the outer membrane (De Lay & Cronan, 2008). Therefore, we 
made a similar deletion of the C-terminus of the S. flexneri pbgA homolog (yejM) to 
determine the effects of eliminating cardiolipin from the outer membrane. Membrane 
fractionation and analysis of the phospholipids confirmed that the mutant lacked 
cardiolipin in the outer membrane. As expected, the phospholipid composition of the 
inner membrane of the pbgA mutant looked identical to the WT (Figure 11A). 
Interestingly, unlike the clsA mutant, which had increased amounts of PG within its 
membrane in the absence of cardiolipin, the pbgA outer membrane did not have increased 
PG levels. Complementation with full-length pbgA on a plasmid restored cardiolipin in 
the outer membrane. In addition, we determined that the whole cell phospholipid profile 
was not disrupted in the pbgA mutant when compared to wild type (WT) (Figure 12). 
Together, this suggests that S. flexneri PbgA is responsible for transporting cardiolipin 






 pbgA mutant has wild-type cardiolipin levels. Figure 12.
TLC analysis of total S. flexneri membrane phospholipids of the pbgA mutant. 
Bacteria were grown to mid-log phase, and phospholipids were extracted and separated 
by TLC. Phospholipids were visualized using molybdenum blue spray (Sigma). The 
percentage of cardiolipin in the sample is indicated above each lane. The phospholipids 





1.5 S. FLEXNERI CLSA IS HIGHLY EXPRESSED IN VITRO. 
Because S. flexneri shares a large proportion of genetic homology with E. coli, 
and the genetic landscapes surrounding all cardiolipin synthases are conserved, it is 
possible that the contribution to cardiolipin synthesis by ClsB and ClsC in S. flexneri is 
reduced because they are not expressed. During exponential growth, S. flexneri clsA was 
induced approximately 100-fold compared to E. coli clsA, and clsC was induced 
approximately 5-fold (Figure 13). However, S. flexneri clsB expression mimicked E. coli, 
suggesting the inactivity of ClsB is unrelated to its expression. The high expression of 






 mRNA levels of S. flexneri clsA are highly expressed compared to E. coli. Figure 13.
Expression of clsA is increased in S. flexneri as determined by quantitative real-
time PCR. Bacteria were subcultured 1:100 into LB and grown to mid-log phase and 
RNA from approximatly108 CFU was isolated and used to determine message levels. 
Threshold cycle (CT) values were normalized against those for accD, analysis was 
performed using the ΔΔCT approach and are shown relative to the E. coli level set to 1. 





1.6 S. FLEXNERI PBGA IS HIGHLY EXPRESSED IN VITRO. 
The genetic landscapes surrounding the encoded cardiolipin transporter pbgA are 
conserved between S. flexneri and E. coli; however, during exponential growth, S. 
flexneri pbgA was induced approximately 5-fold compared to E. coli pbgA (Figure 13). 
The higher expression of pbgA in S. flexneri could contribute to an increased amount of 
cardiolipin in the outer membrane of S. flexneri compared to E. coli. An E. coli mutation 
in pbgA results in a reduction of outer membrane integrity (Hirvas et al., 1997). The 
increase in cardiolipin could increase the outer membrane integrity of S. flexneri, 
allowing them to survive more harsh conditions than E. coli. 
 
1.7 CHAPTER 1 CONCLUSION. 
Cardiolipin is a large anionic phospholipid, which makes up approximately 7% of 
S. flexneri‘s membrane phospholipids. Cardiolipin specifically localizes to the inner 
leaflet of the bacterial poles (Oliver et al., 2014). This is because cardiolipin has a small 
glycerol head group and a large acyl region with 4 chains, giving the overall structure of 
cardiolipin a conical shape. Bacteria lacking cardiolipin do not have altered cell 
morphology, supporting the model that the conical shape of cardiolipin does not dictate 
the negative curvature of the poles, but that its localization at the poles is a consequence 
of its shape. Cardiolipin localizes to bacterial poles via diffusion because of its natural 
tendency to destabilize planar membranes. 
Analysis of S. flexneri phospholipids revealed that cardiolipin makes up 
approximately 7% of its total phospholipids and is found in equal amounts between the 
inner and outer membrane. We determined that ClsA is the major cardiolipin synthase of 




membrane in the absence of cardiolipin, which maintains the overall anionic 
phospholipid levels (Figure 14). In addition, we determined that PbgA transports 
cardiolipin and phosphatidylglycerol to the S. flexneri outer membrane, but has no effect 






 Schematic of proposed phospholipid localization in WT, clsA, and pbgA Figure 14.
mutants. 
clsA and pbgA have different membrane composition compared to the wild type. 
(WT) the inner and outer membranes are identical. Cardiolipin localizes to the bacterial 
pole, phosphatidylglycerol localizes adjacent to cardiolipin, and phosphatidylglycerol 
localizes to non-polar regions. (clsA) the inner and outer membrane are identical; 
however, they do not contain cardiolipin and have increased phosphatidylglycerol levels. 
(pbgA) the inner membrane is identical to WT, while the outer membrane does not 
contain cardiolipin and has reduced phosphatidylglycerol. Phospholipids include; 





2. Chapter 2: Role of Cardiolipin in Pathogenesis2 
To cause disease, S. flexneri must efficiently invade colonic epithelial cells and 
spread intercellularly to neighboring cells. Previous studies have shown that outer 
membrane integrity, mediated by asymmetric distribution of phospholipids and Lipid A 
structure, is required by S. flexneri during intercellular spread (Carpenter et al., 2014); 
however, the role of specific phospholipids in S. flexneri pathogenesis had not been 
determined.  
Much remains unknown regarding cardiolipin’s role in bacterial membranes and 
this is likely for two reasons. First, most enteric bacteria have three cardiolipin synthases, 
and all three must be inactivated in order to eliminate cardiolipin from the bacterial 
membrane; most studies to date have only been performed on bacteria with reduced 
cardiolipin levels. Second, phosphatidylglycerol, which is similar to cardiolipin in that it 
also has a glycerol head group and is an anionic phospholipid, can interact with proteins 
in a similar manner and compensate for the lack of cardiolipin within the bacterial 
membrane. Thus, bacteria lacking cardiolipin do not display an in vitro growth 
phenotype. These concerns have complicated studying cardiolipin’s role in bacterial 
pathogenesis. Here we assay the S. flexneri cardiolipin synthesis and transport mutants’ 
ability to form plaques in cultured epithelial monolayers to assess for virulence (Oaks et 
al., 1985). 
 
                                                
2 Portions of this work have been previously published in mBio (Rossi, R. M., Yum, L., Agaisse, H. & 
Payne, S. M. (2017). Cardiolipin Synthesis and Outer Membrane Localization Are Required for Shigella 
flexneri Virulence. mBio 8, e01199–17.) by the American Society for Microbiology. R. M. Rossi designed 




2.1 CARDIOLIPIN SYNTHESIS BY CLSA IS REQUIRED FOR PLAQUE FORMATION. 
To determine the role of cardiolipin in S. flexneri pathogenesis, we performed 
plaque assays (Oaks et al., 1985) with each of the cardiolipin synthesis mutants. S. 
flexneri is an intracellular pathogen, and plaque formation requires invasion of the Henle 
cell monolayer, intracellular replication, and spread to the adjacent cells. After 72 hours, 
the clsA mutant formed pinpoint plaques compared to WT. Plaque formation was 
complemented by clsA on a plasmid (Figure 15). This suggests cardiolipin synthesis by 






 clsA and pbgA are required for S. flexneri plaque formation. Figure 15.
Confluent monolayers of Henle cells were infected with approximately 104 CFU 
of bacteria. Monolayers were stained and photographed after 72 h to visualize plaque 





2.2 EXPRESSION OF CLSB AND CLSC INCREASE DURING INTRACELLULAR GROWTH. 
Because ClsC contributed to cardiolipin synthesis in stationary phase (Figure 10), 
it was possible that clsB or clsC is expressed in the intracellular environment and 
contributed to sufficient cardiolipin to support formation of very small plaques. Analysis 
of intracellular mRNA levels revealed that both clsB and clsC were induced 
approximately 10-fold in the intracellular bacteria (Figure 16), while clsA was 






 clsB and clsC expression increase in the intracellular environment. Figure 16.
Quantification of cardiolipin synthases and transport genes, determined using 
quantitative real-time PCR. Bacteria were sub-cultured 1:100 into LB + 0.01% DOC and 
grown to mid-log phase. Cultures were divided, and RNA from approximately 108 CFU 
was isolated and used to determine extracellular message levels, and semi-confluent 
Henle-407 monolayers were infected with the remaining approximately 108 CFU. RNA 
was isolated 4 hours post infection, by lysing infected monolayer with RNA-Bee, and 
used to determine intracellular mRNA levels. Threshold cycle (CT) values were 
normalized against those for accD. Analysis was performed using the ΔΔCT approach and 




compared to extracellular expression levels (by Student’s t-test). Figure taken from 





2.3 CLSB AND CLSC DO NOT CONTRIBUTE TO CARDIOLIPIN SYNTHESIS DURING 
PLAQUE FORMATION. 
Since expression of clsB and clsC increase in the intracellular environment, it is 
possible that they may contribute to cardiolipin synthsis during plaqe formation. 
However; mutation in clsB and clsC did not affect S. flexneri plaque formation (Figure 
15), indicating that that ClsB and ClsC do not synthesize sufficient cardiolipin in 
intracellular bacteria to compensate fully for the loss of clsA. 
 
2.4 TRANSPORT OF CARDIOLIPIN TO THE OUTER MEMBRANE IS REQUIRED FOR 
PLAQUE FORMATION. 
Next, we wanted to determine if cardiolipin is required in the outer membrane of 
S. flexneri for plaque formation, therefore we test the pbgA mutant that does not have 
cardiolipin within it outer membrane. The pbgA mutant was unable to form plaques 
compared to WT (Figure 15), and displayed a similar plaque phenotype to an icsA mutant 
that is unable to spread intercellularly. Plaque formation by the pbgA mutant was restored 
by full-length pbgA on a plasmid. This indicates that cardiolipin within the outer 
membrane is critical for plaque formation. The clsA and pbgA mutants were further 
characterized to determine more precisely the roles of cardiolipin in S. flexneri virulence. 
 
2.5 CARDIOLIPIN IS NOT REQUIRED FOR S. FLEXNERI MAINTENANCE OF MEMBRANE 
INTEGRITY. 
Previous studies have show that a disruption in the outer membrane integrity 
inhibits S. flexneri plaque formation (Carpenter et al., 2014), and pbgA is required to 
maintain membrane integrity in other Gram-negative bacteria (Dalebroux et al., 2015; 
Hirvas et al., 1997). To determine whether the defect in plaque formation by clsA and 




cardiolipin, we assessed the mutants for increased sensitivity to Deoxycholate (DOC), an 
ionic bile acid that disrupts the membrane. The clsA and pbgA mutants grew similar to 
the wild type, with an average doubling time of 41 min, both in the absence (Figure 17A) 
and presence (Figure 17B) of DOC. In contrast, the vpsC mutant, which has 
compromised outer membrane stability (Carpenter et al., 2014), was inhibited in the 
presence of DOC. 
Interestingly, in the presence of DOC, the expression of clsA, clsB, clsC, and 
pbgA all increase (Figure 18), suggesting there may be regulation of cardiolipin synthesis 
and transport under membrane stress conditions similar to S. Typhimurium (Dalebroux et 
al., 2014). However, because membrane integrity remains, this suggest that cardiolipin 
within the outer membrane of S. flexneri is not playing a structural role in the integrity of 






 Cardiolipin synthesis and outer membrane transport are not required Figure 17.
for growth in the presence of DOC. 
clsA and pbgA mutant strains do not exhibit growth sensitivity to DOC. (A) 
Bacteria were subcultured 1:100 into LB (A), or LB containing 0.1% DOC (B), and 






 Cardiolipin synthase and transport gene expression increases in the Figure 18.
presence of DOC. 
As determined by quantitative real-time PCR. Bacteria were subcultured 1:100 
into LB and grown to mid-log phase and RNA from approximately108 CFU was isolated 
and used to determine message levels. Threshold cycle (CT) values were normalized 
against those for accD. Analysis was performed using the ΔΔCT approach and values are 
shown relative to the extracellular level set to 1. (*) P-value of <0.05 compared to the 





2.6 CARDIOLIPIN IS NOT REQUIRED FOR CELLULAR INVASION. 
The initial stage of S. flexneri virulence requires the bacteria to invade colonic 
epithelial cells (Labrec et al., 1964; Oliver et al., 2014). A requirement for cardiolipin in 
invasion would give fewer or no plaques. To determine if cardiolipin is required for 
invasion, we compared the clsA and pbgA mutants with wild type and found that neither 
mutant had a significant defect in invasion compared to the wild type parental strain 
(Figure 19). Infection rates were determined for cells grown in the presence and absence 
of DOC, since previous work (Pope et al., 1995) had shown that DOC increased 






 Cardiolipin synthesis and outer membrane transport are not required Figure 19.
for S. flexneri invasion. 
Invasion rates of clsA and pbgA mutants.  Percent of Henle cells that contained 3 
or more intracellular bacteria. The data represent mean values of three biological 
replicates with standard deviation. Compared to wild type, none of the mutants had a 






2.7 CARDIOLIPIN IS NOT REQUIRED FOR INTRACELLULAR GROWTH. 
Once inside the epithelial cell the bacteria rapidly replicate (Sansonetti et al., 
1986). A requirement for cardiolipin in this process could explain reduced plaque 
formation. To assess intracellular replication, we isolated intracellular bacteria at 60 and 
180 min post-infection and determined their doubling time. We found that compared to 
WT, neither the clsA nor the pbgA mutant had a significant defect in intracellular 
replication (Figure 20). Together, these data indicate cardiolipin is not required in the 
inner or outer membrane of S. flexneri for Henle cell invasion and intracellular replication 






 S. flexneri pbgA and clsA mutants replicate similar to WT intracellularly. Figure 20.
Doubling time of bacteria during the first three hours of intracellular growth. The 
numbers of intracellular bacteria were determined by lysing infected Henle monolayers, 
followed by plating of the lysate dilutions. Cell counter were normalized to the 1 hour 
time point. Data represent the mean values of three biological replicates and 
standard deviations. Compared to wild type, none of the mutants had a statistical or 





2.8 CARDIOLIPIN IS REQUIRED FOR CELLULAR DISSEMINATION. 
The lack of an effect of cardiolipin on invasion and intracellular replication 
suggested that the plaque defect was due to lack of cell-to-cell spread of the bacteria. To 
determine the role of cardiolipin in S. flexneri intercellular spread, we determined the 
percentage of primary Henle cell infections resulting in spread to neighboring cells after 
4 hours, using a cell-to-cell spread assay (Carpenter et al., 2014). Primary infected Henle 
cells were identified as cells containing large numbers of bacteria, indicating intracellular 
replication (Figure 21A). Infective centers were scored positive for spread if one or more 
neighboring cells had 3 or more intracellular bacteria. After 4 hours, wild type S. flexneri 
had spread from > 80% of the initially infected cells to neighboring cells (Figure 21B). 
The clsA and pbgA mutants, however, had significant defects in intercellular spread, with 
a spread rate of only 20 and 24%, respectively. This rate mimicked the rate of an icsA 
mutant that cannot spread (Bernardini et al., 1989). The intercellular spread defect of 
both the clsA and pbgA mutants could be complemented by the addition of the full-length 
protein expressed from a plasmid. This suggests the defect in plaque formation of both 






 Cardiolipin is required for S. flexneri intercellular spread. Figure 21.
Semiconfluent Henle monolayers were infected with approximately 107 CFU of 
bacteria. Monolayers were stained after 4 hr, and intercellular spread was visualized by 
bright-field microscopy. (A) Micrographs of intercellular spread by WT S. flexneri and 
clsA, pbgA, and icsA mutants. Black arrows point to primary infected Henle cells. (B) 
Graphical representation of S. flexneri intercellular spread. One hundred infected Henle 
cells were counted positive for spread if the surrounding Henle cells were also infected. 
Values are means and standard deviations (error bars) for three biological replicates. 
Values that are significantly different (P < 0.05) from the value for the wild type by 





2.9 CLSA IS REQUIRED FOR FOCI FORMATION IN HT-29 CELLS. 
Intercellular spread of S. flexneri is a dynamic, multi-step process (Agaisse, 
2016); it requires the bacteria to polymerize host actin to move and penetrate neighboring 
cells (Philpott et al., 2000), re-activate their T3SS to eject effector proteins into 
neighboring cell cytoplasm (Campbell-Valois et al., 2014), and resolve the membrane 
protrusions into neighboring cells (Kuehl et al., 2014). To specifically determine at which 
point during intercellular spread the clsA and pbgA mutants have a defect, we used 
infection of HT-29 intestinal cells, which allowed us to employ time-lapse confocal 
microscopy to monitor cell-to-cell spread over an extended period of time (Dragoi & 
Agaisse, 2014). First, using computer-assisted image analysis, cell-to-cell spread was 
quantified by measuring the area of the infected foci in cellular monolayers.  
Although the clsA mutant showed a defect in spread within 4 hours in Henle cells, 
the decrease in foci area in HT-29 cells was not detected until 8-16 hours of infection. At 
16 hours, the clsA mutant showed a significant decrease in foci area compared to the WT 
(Figure 22A), and this defect in intercellular spread was complemented with full-length 






 clsA has reduced dissemination in HT-29 cells after 16 hours. Figure 22.
(A) Low-magnification image of WT and clsA mutant foci and small plaque 
formation at 16 h to determine their size. (B) Quantification of WT and clsA mutant foci 
and small plaque formation at 16 h. Values that are significantly different (P < 0.0001) by 






2.10 CARDIOLIPIN SYNTHESIS IS REQUIRED FOR PROPER INTRACELLULAR DIVISION OF 
S. FLEXNERI.  
Using the HT-29 intestinal cell line model, we analyzed the timing of cell-to-cell 
spread of the clsA mutant by time-lapse confocal microscopy (Kuehl et al., 2014). HT-29 
cell monolayers expressing plasma membrane-targeted yellow florescence protein (YFP) 
were infected with S. flexneri expressing IPTG-inducible cyan fluoresces protein (CFP), 
and individual bacteria were tracked. The wild-type strain showed rapid cell division, 
motility and spread to adjacent cells (Rossi et al., 2017). The clsA mutant (Rossi et al., 
2017) appeared similar to the wild type at the early time points. It was motile in the 
initially infected cell and had normal intracellular growth for the first 6 hours (Figure 23). 
However, after an extended period of time (6 hrs), independent of the bacteria 
being in the cytoplasm of the primary infected cell or neighboring cells, the clsA mutant 
was no longer able to divide properly and formed filaments (Figure 24). Filamenting 
bacteria were non-motile, which inhibited further spread, or they formed protrusions that 
were unable to form vacuoles and retracted back into the cell. Thus, cardiolipin is 







 clsA behaves like wild type early during intracellular growth. Figure 23.
Basal Z-section slice of the HT-29 monolayer footprint prior to infection and 
early infection tracking of a normal growing bacterium. Arrowhead tracking of a 
bacterium about to divide at 22 min (22’), which gives rise to two bacteria shown at 24 
min, indicated by an arrowhead and asterisk. The arrowhead was tracked until the next 






 clsA is required for intracellular division late during intracellular Figure 24.
growth. 
Basal Z-section slice of the HT-29 monolayer footprint tracking of an abnormally 
growing bacterium. Late infection tracking of one cytosolic filamenting bacterium at 160 





2.11 INNER MEMBRANE CARDIOLIPIN IS REQUIRED FOR PROPER CELL DIVISION DURING 
INTRACELLULAR GROWTH. 
Unlike the clsA mutant, after 8 hours, the pbgA mutant showed a significant 
decrease in the area of intercellular spread in HT-29 cells compared to WT (Figure 25A), 
and this impairment in intercellular spread was complemented with full-length pbgA on a 
plasmid (Figure 25B). This indicates that outer membrane cardiolipin is required for S. 
flexneri intercellular spread early in infection. The delay in a detectable spread defect for 
the clsA mutant compared to the pbgA mutant may be due to partial compensation by the 
increased PG in the outer membrane of the clsA mutant. 
To more precisely define whether the defect in intracellular replication in the 
cardiolipin synthesis mutant (clsA) was due to lack of cardiolipin in the inner or the outer 
membrane, we also performed time-lapse microscopy on the pbgA mutant, which has 
cardiolipin in the inner, but not the outer, membrane (Rossi et al., 2017). Unlike the clsA 
mutant, the pbgA mutant grew normally within the cytoplasm of HT-29 cells, indicating 
that cardiolipin is needed in the inner membrane for maintaining wild type replication in 
the intracellular environment. However, the pbgA mutant was non-motile inside the 
eukaryotic cell and did not spread intercellularly. Thus, cardiolipin in the outer membrane 
is needed for intracellular motility.  
For comparison, the vpsC mutant, which has altered phospholipids and lipid A 
modifications in the outer membrane (Carpenter et al., 2014), was analyzed (Rossi et al., 
2017). The vpsC mutant had an intracellular infection phenotype that was distinct from 
either of the cardiolipin mutants. It replicated normally and was motile, but the motility 






 pbgA has reduced dissemination in HT-29 cells after 8 hours. Figure 25.
 (A) Low-magnification image of WT and pbgA mutant focus formation at 8 h to 
determine their size. (B) Quantification of WT and pbgA mutant focus formation at 8 h. 
Values that are significantly different (P 0.0001) by Student’s t test are indicated by a bar 





2.12 OUTER MEMBRANE ANIONIC PHOSPHOLIPIDS ARE REQUIRED FOR ICSA 
LOCALIZATION. 
Since the pbgA mutant was non-motile within the intracellular environment, it 
suggests that it has a defect in the localization or export of IcsA. To determine if 
cardiolipin within the outer membrane is required for IcsA localization, we used indirect 
immunofluorescence directed against IcsA to visualize surface IcsA localization of S. 
flexneri grown in vitro (Purdy et al., 2007). When compared to WT, the pbgA mutant 
displayed no polar localization of IcsA (Figure 26), and had a low amount of IcsA 
detectable across its entire outer surface. Unipolar localization of IcsA was restored with 
full-length pbgA on a plasmid. For comparison, the icsA mutant had no detectable IcsA 
on its surface. This suggests that the lack of cardiolipin within the outer membrane of the 
pbgA mutant inhibits unipolar IcsA localization.  
Since the clsA mutant was motile within the cytoplasm of HT-29 cells, we 
predicted that IcsA could still be localized to the bacterial pole. We found that in the clsA 
mutant (Figure 26), IcsA was localized to the poles; however, the amount of IcsA was 






  pbgA is required for unipolar IcsA localization. Figure 26.
Surface localization of polar IcsA, visualized by indirect immunofluorescence. 
Bacterial cultures were gown to mid-log phase (visualized by phase contrast microscopy), 
and IcsA was observed by indirect immunofluorescence (visualized by FITC). All images 
were captured with an exposure time of 1.5 s and processed in an identical manner. Bar = 





2.13 CHAPTER 2 CONCLUSION 
To date, roles of cardiolipin in bacterial pathogenesis have been identified in two 
pathogens, S. Typhimurium (Dalebroux et al., 2015) and Moraxella catarrhalis (Buskirk 
& Lafontaine, 2014). In S. Typhimurium cardiolipin is required in the outer membrane to 
provide membrane integrity. Increased expression of pbgA and remodeling of the outer 
membrane occurs in response to PhoPQ signaling during Salmonella infection, 
Salmonella, like Shigella, is an intracellular pathogen; however, Salmonella resides 
within phagosomes of macrophages, which may represent a more stressful environment 
than the cytoplasm. Since S. flexneri lacking cardiolipin does not have reduced membrane 
integrity when grown in the presence of DOC, and does not have an in vivo growth 
defect, it is unlikely that the role of cardiolipin in S. flexneri pathogenesis is maintenance 
of S. flexneri membrane integrity.  
In Moraxella catarrhalis, cardiolipin is required for proper bacterial attachment to 
human epithelial cells (Buskirk & Lafontaine, 2014). It is hypothesized that cardiolipin is 
required for the localization or display of adhesion proteins. This may represent a similar 
function to cardiolipin’s role in S. flexneri, where cardiolipin in the outer membrane is 
important for the localization of IcsA. 
In the absence of cardiolipin, phosphatidylglycerol localizes to the bacterial pole 
and can interact with polar proteins, in the same, but less efficient manner as cardiolipin. 
We predict that in cardiolipin’s absence in S. flexneri, other anionic phospholipids, such 
as phosphatidylglycerol, can help localize IcsA to the pole; however, this localization is 
not as specific or as efficient as when cardiolipin is present. This model is supported by 
the phenotype of a pbgA mutant, in which the absence of cardiolipin and an overall 




pattern of IcsA on the surface of S. flexneri and a more severe phenotype in the spread 
and motility assays. 
The loss of cardiolipin from the outer membrane without compensation by 
increased PG affects plaque formation by preventing IcsA localization. The effects of 
loss of cardiolipin from the inner membrane are less clear. The clsA mutant replicates 
normally in vitro and has no obvious defect early in infection of epithelial cells.  
However, longer exposure to the intracellular environment results in aberrant cell 
division and loss of motility. Studies in E. coli have shown that MinD, which is required 
for normal cell division, and osmotic stress proteins associate with cardiolipin in the inner 
membrane. Similar effects of cardiolipin on localization of inner membrane proteins in S. 
flexneri could cause the growth defects seen in the host cell cytoplasm. 
Since the pbgA mutant maintains wild type levels of cardiolipin within the inner 
membrane, it suggests inner membrane cardiolipin is required for intracellular division 
(Figure 27), while the clsA mutant outer membrane has increased phosphatidylglycerol to 
compensate for the lack of cardiolipin, suggesting outer membrane anionic phospholipids 






  Schematic of outer and inner membrane localizing S. flexneri virulence Figure 27.
proteins. 
(WT) IcsA localizes to cardiolipin and PG in the outer membrane, and an unknown 
intracellular division protein localizes with cardiolipin in the inner membrane. (clsA) 
Most IcsA localizes with PG in the outer membrane, reducing intracellular movement. 
An unknown intracellular division protein does not have cardiolipin to localize to in the 
inner membrane, inhibiting intracellular division. (pbgA) IcsA does not have cardiolipin 
or PG to localize to in the outer membrane, inhibiting intracellular movement. An 
unknown intracellular division protein localizes with cardiolipin in the inner membrane. 






3. Chapter 3: Interaction of Cardiolipin and IcsA3 
Unipolar localization of S. flexneri virulence protein, IcsA, provides the 
mechanism for intracellular mobility through the polymerization of host actin, which is 
required for intercellular spread. S. flexneri IcsA is a member of the auto-transporter 
protein family, where its C-terminus functions as a beta-barrel in the outer membrane, 
and its N-terminal domain is fed through the barrel to expose the N-WASP recruitment 
domain on the surface of the bacteria. The direct mechanism by which IcsA localizes to 
the bacterial pole remains unknown. Here we examine the role of cardiolipin in polar 
targeting of IcsA. 
 
3.1 ROLE OF CARDIOLIPIN IN ICSA LOCALIZATION IS INDEPENDENT OF 
LIPOPOLYSACCHARIDE STRUCTURE. 
Mis-localization of IcsA by the loss of outer membrane cardiolipin in the clsA and 
pbgA mutants could be an indirect. The one current model for S. flexneri IcsA polar 
localization suggests localization is directed by outer membrane O-antigen chain length 
synthesis (Doyle et al., 2015a). To determine whether the absence of cardiolipin disrupts 
O-antigen synthasis of S. flexneri, we compared the LPS of clsA and pbgA mutants to the 
wild type and to a previously characterized rol LPS mutant (Hong & Payne, 1997) by gel 
electrophoresis (Figure 28). The clsA and pbgA mutants did not have any detectable 
differences in LPS chain lengths when compared to WT. This suggests that the role of 
cardiolipin in S. flexneri IcsA localization is independent of O-antigen chain length. 
  
                                                
3 Portions of this work have been previously published in mBio (Rossi, R. M., Yum, L., Agaisse, H. & 
Payne, S. M. (2017). Cardiolipin Synthesis and Outer Membrane Localization Are Required for Shigella 
flexneri Virulence. mBio 8, e01199–17.) by the American Society for Microbiology. R. M. Rossi designed 





 Cardiolipin is not required to maintain LPS structure. Figure 28.
LPS structure of clsA and pbgA mutants are similar to the wild type. Bacteria 
were grown to mid-log phase. LPS was extracted, resolved by (4 to 12%) SDS-PAGE, 





3.2 CARDIOLIPIN IS NOT REQUIRED FOR ICSA TRANSPORT TO THE OUTER MEMBRANE 
Although the anionic lipids cardiolipin and phosphatidylglycerol are known to be 
capable of localizing membrane proteins, the disruption in localization of IcsA could be 
indirect. This disruption in localization of IcsA could be a result of inefficient export of 
IcsA to the outer membrane (Purdy et al., 2002). To determine whether cardiolipin plays 
a role in efficient transport of IcsA to the outer membrane, we fractionated the inner and 
outer membranes of S. flexneri and examined the IcsA levels in each membrane using 
immunoblot analysis. We found that both the clsA and pbgA mutants had WT levels of 
IcsA within their outer membrane (Figure 29), indicating that cardiolipin is not necessary 






 Cardiolipin is not required to maintain outer membrane IcsA levels. Figure 29.
Outer membrane IcsA levels. Bacteria were grown to mid-log phase. The 
membranes were fractionated using Sarkosyl membrane solubilization, resolved by 
(10%) SDS-PAGE, stained by Coomassie blue (CB) (Same gel pictured in Figure 11), 
and immunoblotted using polyclonal anti-IcsA antisera. C, cytoplasm; IM, inner 





3.3 OUTER MEMBRANE CARDIOLIPIN IS NOT REQUIRED FOR ICSA PASSENGER DOMAIN 
AUTO-TRANSPORT. 
Upon reaching the outer membrane, the IcsA beta-barrel is first inserted into the 
outer membrane, and auto-transport of the IcsA passenger domain follows (Figure 6). 
However, we don’t know if auto-transport follows immediately or only when IcsA is at 
the bacterial pole. It is possible that cardiolipin targets periplasmic IcsA directly to the 
outer membrane pole for beta-barrel insertion and subsequent transport of the N-terminal 
domain, and in the absence of cardiolipin insertion and transport is non-directed resulting 
in a more circumferential IcsA pattern. Alternatively, the periplasmic IcsA beta-barrel 
can be inserted anywhere in the outer membrane but N-terminal transport of IcsA can 
only occur when it interacts with cardiolipin, and in the absence of cardiolipin there is a 
reduced amount of N-terminal extracellular exposed IcsA. Since the IcsA antibody is 
against the passenger domain, visualization of polar IcsA only showed surface exposed 
IcsA (Figure 26). 
To differentiate between these mechanisms, we analyzed the amount of surface 
exposed IcsA passenger domain in the clsA and pbgA mutants. Using extracellular trypsin 
protease, we can measure the amount of surface exposed peptides, which are sensitive to 
protease digestion, compared to transmembrane and periplasmic proteins that are not 
surfaced exposed (Besingi & Clark, 2015). Sonication followed by digestion with trypsin 
resulted in the complete degradation of S. flexneri IcsA passenger domain (Figure 30), 
and IcsA levels were restored in a dose dependent manner in the absence of sonication. 
Periplasmic DegP levels were only disrupted in the presence of sonication, and outer 





When compared to the wild type, both the clsA and pbgA mutant had similar 
amounts of surface exposed IcsA (Figure 30). This suggests that outer membrane 
cardiolipin is not required for passenger domain auto-transport, but outer membrane 
cardiolipin is required to direct the cPT domain to the bacterial pole for beta-barrel 






 clsA and pbgA mutants have wild type levels of surface exposed IcsA. Figure 30.
Western blot analysis of IcsA, DegP and OmpA levels in the wild type, clsA and 
pbgA mutants after trypsin exposure. Bacterial cells were grown to mid-log, sonicated (S) 
and exposed to varying concentrations of trypsin. Samples were run on (12%) SDS-






3.4 CARDIOLIPIN IS REQUIRED FOR POLAR TARGETING OF ICSA. 
Directing of polar fluorescence to the bacterial pole by the IcsA cPT domain has 
been observed in other Gram-negative bacteria (Charles et al., 2001; Janakiraman et al., 
2009), and this polar targeting is independent of secretion to the outer membrane. This 
suggests a conserved characteristic between all Gram-negative bacterial inner and outer 
membrane inner leaflets at the poles affect polar targeting of the cPT domain. Since 
cardiolipin is conserved between the inner leaflets of the Gram-negative bacterial 
membrane, we hypothesize cardiolipin may be directing polar targeting of IcsA via the 
cPT domain. 
To determine if cardiolipin directs IcsA polar targeting via the cPT domain we 
constructed a fluorescent fusion protein of GFP to the cPT domain of IcsA and examined 
polar GFP in the clsA mutant (Figure 31A). When compared to the wild type and pbgA 
mutants, which have cardiolipin within their inner membrane, the clsA had reduced polar 
targeting of GFP (Figure 31B) suggesting cardiolipin directs polar targeting of IcsA via 






 cPT polar targeting is disrupted in the clsA mutant. Figure 31.
IcsA502-620-GFP fusions expressed in the WT, clsA and pbgA mutants. (A) 
Bacterial cultures were grown to mid-log phase and IcsA polar targeting was observed by 
GFP fluorescence. (B) Quantification of polar foci frequency (n=200). All images were 






3.6 ICSA PASSENGER DOMAIN DIRECTLY INTERACTS WITH CARDIOLIPIN 
In the inner mitochondrial matrix, lysine residues on the surface of Drp1 interact 
with the glycerol head group of cardiolipin, helping it localize with cardiolipin. It is 
possible that positively charged residues on the surface of the polar targeting (PT) 
domain identified in the N-terminal region of IcsA help IcsA localize with cardiolipin. 
Alternatively, cardiolipin could indirectly localize IcsA by interacting with the positively 
charged residues of other proteins known to aid in its localization and activity. For 
example, IcsA chaperone or secretion proteins may interact with cardiolipin to direct 
insertion of IcsA into the outer membrane at the poles. These interactions would promote 
polar localization of IcsA to allow directed movement by actin polymerization at the 
bacterial surface. 
To determine if the interaction between the IcsA cPT domain and cardiolipin is 
direct, we purified the IcsA passenger domain (Leupold et al., 2017) and assessed its 
ability to interact with phospholipids using protein-lipid co-sedimentation assays. After 
protein-lipid incubation, if the protein is able to interact with the respective phospholipid, 
the protein will co-sediment with the lipid following centrifugation (Zhao & Lappalainen, 
2012). In the absence of phospholipid, IcsA is found in the supernatant fraction (Figure 
32A), while incubation with positively charged phosphatidylethanolamine resulted in a 
small fraction of the protein in the pellet, suggesting IcsA binds poorly to 
phosphatidylethanolamine. 
A significant shift in IcsA found in the pellet fraction is observed when it is co-
incubated with negatively charged phosphatidylglycerol (Figure 32A), and this 
interaction can be disrupted with the addition of Mg2+. However, the most significant 




cardiolipin (Figure 32A). Together, this suggests that the IcsA passenger domain is a 






 IcsA cPT domain directly interacts with cardiolipin. Figure 32.
Protein-lipid co-sedimentation assay of the IcsA (A) wild type, and (B) 
Arg564Ala mutant. Proteins were incubated with phospholipids and centrifuged. 
Supernatant (S) and Pellet (P) fractions were isolated, and then analyzed by SDS-PAGE 
and subsequent Coomassie staining. Phospholipids include; phosphatidylethanolamine 





3.7 ICSA AMINO ACID ARG546 IN THE CPT DOMAIN IS IMPORTANT FOR POLAR 
TARGETING. 
Previous studies have identified two intrinsic domains that direct IcsA to the 
bacterial pole (Charles et al., 2001; Doyle et al., 2015b), nPT and cPT (Figure 8). 
Mutational (Doyle et al., 2015b) and structural (Leupold et al., 2017) studies have 
elucidated a specific amino acid residue that directs the cPT domain to the bacterial pole. 
This residue, IcsA-Arg564, is surface exposed and does not play a role in maintaining 
IcsA structure. An amino acid substitution to an Ala maintains total protein levels and 
outer membrane IcsA levels (Table 5.); however, it reduces the amount of polar IcsA and 
S. flexneri plaquing efficiency. This suggests this residue is required for direct polar 
targeting of IcsA. 
Comparing the phenotypes of S. flexneri clsA and pbgA mutants to icsA 
Arg564Ala identified a similarity between the clsA and icsA Arg564Ala mutation (Table 
5.). Both mutations reduce S. flexneri plaquing efficiency, and this is a direct result of 





Table 5. Comparisons of icsA Arg564Ala, clsA, and pbgA. 
Mutant/ 
Characterization 
icsA Arg564Ala clsA pbgA 
Plaque Pinpoint Pinpoint None 
Total IcsA WT WT WT 
Outer Membrane IcsA WT WT WT 
Surface Polar IcsA Reduced Reduced Pinpoint 





3.8 ICSA CPT DOMAIN ARG564 IS REQUIRED FOR CARDIOLIPIN INTERACTION. 
Cardiolipin has previously been shown to directly interact with positively charged 
protein residues (Duncan et al., 2016). Therefore, we hypothesized that the IcsA 
passenger domain was interacting with cardiolipin via the positively charged Arg564 
residue, shown previously to be required for polar targeting of the IcsA cPT domain 
(Doyle et al., 2015b). We purified the IcsA passenger domain containing the amino acid 
substitute Arg564Ala, and determined its ability to interact with cardiolipin. When 
compared to the wild type IcsA, IcsA-Arg564Ala was significantly reduced in its ability 
to interact with the anionic phospholipids phosphatidylglycerol and cardiolipin (Figure 
32B). Together, this suggests that the IcsA passenger domain interacts with cardiolipin at 
amino acid Arg564, within the cPT domain. 
 
3.9 CHAPTER 3 CONCLUSION 
A number of different mechanisms by which S. flexneri localizes IcsA to the 
bacterial pole had been proposed but there was not conclusive evidence for any of theses. 
Here we show that cardiolipin direct IcsA polar localization independent of O-antigen 
chain length, export to the bacterial outer membrane, and exposure of IcsA passenger 
domain to the bacterial surface. 
Comparison of icsAArg564Ala, and clsA mutants revealed similar phenotypes 
involving IcsA localization and plaque formation. We determined that, independent of 
outer membrane transport; polar cardiolipin directs the IcsA cPT domain via a direct 
interaction with Arg564. We propose that outer membrane cardiolipin directs IcsA to the 
bacterial pole by directly interacting with the cPT domain. Once at the bacterial pole, the 




passenger domain to the bacterial surface (Figure 33). In the absence of cardiolipin, the 
passenger domain is still able to interact with outer membrane phospholipid for 
membrane insertion and auto-transport; however, it is not attracted to the bacterial pole, 






 Model for cardiolipin directing polar IcsA localization. Figure 33.
IcsA is transcribed in the cytoplasm and held in a non-folded conformation by 
cytoplasmic chaperone proteins Skp and DnaK (blue filled circles). The signal peptide 
sequence of IcsA directs it to SecA for translocation across the inner membrane and 
subsequent cleavage of signal sequence. Upon periplasmic entry, IcsA begins to fold with 
the help of periplasmic chaperon proteins DegP/SurA/Skp (red filled circles). Arg546 
directs interaction with the bacterial pole by targeting IcsA to cardiolipin (green region). 
Interaction with the outer membrane directs insertion of the IcsA beta-barrel into the 
membrane, followed by transport of the IcsA auto-transport domain. The N-WASP 
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